Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1050.Time spend outdoors in summer,49766,0.0153926035723249,0.0226507950130254,-0.0290029546532049,0.0597881617978546,0.496789931100321
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1060.Time spent outdoors in winter,47694,0.00246900485719052,0.0251349357725351,-0.0467954692569783,0.0517334789713593,0.921750721687343
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1070.Time spent watching television (TV),50931,0.104294225618475,0.0231975188152842,0.0588270887405182,0.149761362496432,6.9627126747498e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1080.Time spent using computer,47727,-0.0164000633067249,0.0224070624817024,-0.0603179057708616,0.0275177791574118,0.464229755364406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1090.Time spent driving,43622,0.0254674394905299,0.0259256526397637,-0.025346839683407,0.0762817186644667,0.325955802463503
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1160.Sleep duration,51712,0.0190223104437481,0.0199530982919982,-0.0200857622085684,0.0581303830960645,0.340422385654133
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35478,-0.0296878804306185,0.0256718536585929,-0.0800047136014605,0.0206289527402235,0.2475464317818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35478,0.0380474982378928,0.0245918552365307,-0.0101525380257075,0.086247534501493,0.121875383077076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35478,0.0217129393115755,0.0268941656008414,-0.0309996252660736,0.0744255038892246,0.419496820115891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35478,0.0175463664139858,0.0271176386259341,-0.035604205292845,0.0706969381208166,0.517625643916198
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35478,0.0262142173907024,0.0271308900053337,-0.0269623270197517,0.0793907618011565,0.333974814300873
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35478,-0.0137614514650098,0.0678776911641742,-0.146801726146791,0.119278823216772,0.839345645463761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35478,0.00739779487416434,0.073017568075972,-0.135716638554741,0.150512228303069,0.919303424479191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35478,-0.0651389912023896,0.0466000915637641,-0.156475170667367,0.0261971882625881,0.162213557658464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35478,-0.00320460325203986,0.0336269072584078,-0.0691133414785192,0.0627041349744395,0.924080549929816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35478,0.0296550586900486,0.0220317451335438,-0.0135271617716973,0.0728372791517945,0.178346245113662
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35478,0.0255476436590647,0.0332591772101683,-0.0396403436728652,0.0907356309909946,0.442433963244661
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35478,0.0114006743002105,0.0177351752307593,-0.0233602691520777,0.0461616177524987,0.520358907022123
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35478,-0.0139029781583741,0.0233358697492566,-0.0596412828669171,0.0318353265501688,0.551345561852836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35478,0.0126931157566153,0.0332832475370336,-0.0525420494159705,0.0779282809292011,0.702944205622628
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35478,0.0261224560490462,0.0314060143455056,-0.0354333320681448,0.0876782441662372,0.405572623690717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35478,0.00295341341440725,0.0490706791398459,-0.0932251176996907,0.0991319445285052,0.95200867098435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35478,-0.0178643927599279,0.0460967176325789,-0.108213959319783,0.0724851737999268,0.698368466499478
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35478,0.0467921957092167,0.0241513419507886,-0.000544434514328972,0.0941288259327623,0.052734211133822
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35478,0.0153994004158798,0.0228770731469726,-0.0294396629521864,0.0602384637839461,0.50088500093143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35478,0.0830953372813788,0.0290000802519829,0.0262551799874923,0.139935494575265,0.00417932862923143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120040.Fatigue severity over the past week,35481,0.049823100897096,0.0400684166928626,-0.0287109958209147,0.128357197615107,0.213748175676336
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120041.Waking unrefreshed severity over the past week,35479,0.0254725828463705,0.0401734039822627,-0.0532672889588644,0.104212454651605,0.526060942770224
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120042.Cognitive symptoms severity over the past week,35481,0.0970399376669476,0.0420957238195179,0.0145323189806925,0.179547556353203,0.021186627700029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120098.Mobility problems today,35485,0.0806491304164938,0.0432611339598951,-0.00414269214490065,0.165440952977888,0.0623345909223318
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120099.Self-care problems today,35485,0.0632394381490431,0.0666048222182158,-0.0673060133986598,0.193784889696746,0.342416909904486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120100.Problems doing usual activities,35485,0.0347114007216332,0.0422718853211245,-0.0481414945077709,0.117564295951037,0.41159409054683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120101.Pain or discomfort today,35485,0.044482896033214,0.0396203965099607,-0.033173081126309,0.122138873192737,0.261596246917032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120102.Anxiety or depression today,35485,0.0446873644345158,0.0502185564373569,-0.0537410061827037,0.143115735051735,0.373576392615863
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120103.Scale to indicate how health is today,35463,-0.00813484465617938,0.00773826000836285,-0.0233018342725706,0.0070321449602118,0.293184374734947
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35461,0.0874474264809385,0.05109199893136,-0.0126928914245272,0.187587744386404,0.0870258187499575
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35451,0.0100750378772431,0.0539441849701861,-0.0956555646643217,0.115805640418808,0.851848735189666
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35466,0.0172138730517573,0.0401299152973529,-0.0614407609310543,0.095868507034569,0.667971703462755
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35465,0.0341018963200831,0.0412427999362519,-0.0467339915549707,0.114937784195137,0.408349608904892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35477,0.105536420097287,0.0583101551283969,-0.00875148395437138,0.219824324148945,0.0703567565035391
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120109.Feeling bad about self over the last two weeks,35457,0.04769089037504,0.0575717810037088,-0.0651498003922292,0.160531581142309,0.407491050574816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120110.Trouble concentrating over the last two weeks,35470,0.049299417470422,0.0567414151818625,-0.0619137562860285,0.160512591226873,0.384965896677848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35469,0.121837581184881,0.0773400212111546,-0.0297488603889821,0.273424022758744,0.11522616938792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35448,0.0986428835147343,0.118274161720727,-0.13317447345789,0.330460240487358,0.404302210417268
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33360,0.140850142900739,0.0570385752062592,0.0290545354964711,0.252645750305007,0.0135744186305034
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49944,0.0494633658784925,0.0492738170918729,-0.0471133156215784,0.146040047378563,0.315464146794151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48193,0.0441696668562614,0.0308167497257831,-0.0162311626062734,0.104570496318796,0.151788397564046
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1289.Cooked vegetable intake,51273,-0.0299984360212862,0.0211938522256732,-0.0715383863836056,0.0115415143410332,0.156956263183078
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50492,-0.0861757795082529,0.0218702355629861,-0.129041441211706,-0.0433101178048002,8.16317612103599e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1309.Fresh fruit intake,51196,0.0333133762503812,0.0217611572809396,-0.00933849202026042,0.0759652445210229,0.125817340547285
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1319.Dried fruit intake,50020,-0.0433216364910042,0.0218571700196595,-0.0861616897295367,-0.000481583252471642,0.0474886499006827
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X134.Number of self-reported cancers,51917,-0.0205489486139543,0.0339279770312849,-0.0870477835952728,0.0459498863673641,0.544744055130497
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X135.Number of self-reported non-cancer illnesses,51918,0.087755707186889,0.0218192375833763,0.0449900015234715,0.130521412850306,5.79067892820474e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X136.Number of operations, self-reported",51918,0.0336271662848046,0.0211724904503177,-0.00787091499781799,0.0751252475674272,0.112244176873293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X137.Number of treatments or medications taken,51918,0.151469160733695,0.0211376391979616,0.11003938790569,0.1928989335617,7.96662337597174e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1438.Bread intake,51309,0.0126856514727648,0.00441949460656657,0.00402344204389428,0.0213478609016352,0.0041036099742703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1458.Cereal intake,50966,0.0801413469434561,0.0208285587873475,0.0393173717202551,0.120965322166657,0.000119588382805578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1488.Tea intake,51230,0.0116247122769327,0.00431066949726785,0.00317580006228777,0.0200736244915777,0.00700772209950146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1498.Coffee intake,50254,0.0102198119999331,0.0209261603200817,-0.030795462227427,0.0512350862272933,0.625289383896225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1528.Water intake,50085,-0.0630105887408802,0.0209739271980921,-0.104119486049141,-0.0219016914326196,0.00266565865524521
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1568.Average weekly red wine intake,44697,-0.197672658721795,0.0246465479039525,-0.245979892613542,-0.149365424830048,1.12979580216658e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,44697,-0.0995697675364341,0.0250738979614519,-0.14871460754088,-0.0504249275319885,7.18788905714619e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1588.Average weekly beer plus cider intake,44743,-0.0414215700274245,0.0279777140209544,-0.0962578895084952,0.0134147494536462,0.138754743565179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1598.Average weekly spirits intake,44681,-0.0466291997111759,0.026391806977297,-0.0983571413866779,0.0050987419643262,0.0772804386125025
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1608.Average weekly fortified wine intake,44724,-0.0223061761329303,0.0397454146106531,-0.10020718876981,0.0555948365039497,0.574651303251049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1737.Childhood sunburn occasions,45718,-0.10628494455733,0.02577178859293,-0.156797650199473,-0.055772238915187,3.7403798065357e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1807.Father's age at death,49798,-0.00862346619157602,0.00417189654655765,-0.016800383422829,-0.000446548960323029,0.038743090171049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1845.Mother's age,32547,-0.000983720155334729,0.0191860717798483,-0.0385884208438375,0.036620980533168,0.959111340098901
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1873.Number of full brothers,51506,0.0425510288097589,0.0200808406373469,0.003192581160559,0.0819094764589589,0.0341026310100224
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1883.Number of full sisters,51512,0.00859488881339264,0.0201793310389964,-0.0309566000230402,0.0481463776498255,0.670166343492008
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20015.Sitting height,51757,-0.00296012029433343,0.005524045295188,-0.0137872490729019,0.00786700848423505,0.592059919766648
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20016.Fluid intelligence score,36617,-0.061385545569553,0.0332958324052059,-0.126645377083756,0.00387428594465051,0.0652754462007828
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20018.Prospective memory result,36976,0.0770827870646384,0.0410429608611062,-0.00336141622312974,0.157526990352406,0.0604048447531148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36500,0.00466683883016112,0.00743055908548422,-0.00989705697738794,0.0192307346377102,0.529984099608641
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36486,0.00525654552741956,0.00744549656431603,-0.00933662773863986,0.019849718793479,0.480208607780979
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20023.Mean time to correctly identify matches,51619,0.00488755649384691,0.00452783525034746,-0.00398700059683411,0.0137621135845279,0.280400283886961
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#1.Illnesses of father_Heart disease,48523,0.0157412456834034,0.00946663417178734,-0.00281335729329974,0.0342958486601066,0.096366016693121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48083,0.00355786638235512,0.0200964151253777,-0.0358311072633851,0.0429468400280954,0.859478983883978
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48049,0.00255919842532516,0.026932549766614,-0.0502285991172383,0.0553469959678886,0.924297958786129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#12.Illnesses of father_Severe depression,48056,-0.0559796294207621,0.0257444984196109,-0.106438846323199,-0.00552041251832466,0.029685186752856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48079,-0.00571295845989071,0.0177864934593545,-0.0405744856402255,0.029148568720444,0.748065080794712
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#2.Illnesses of father_Stroke,48251,-0.0156920079122735,0.0118601573449967,-0.0389379163084671,0.00755390048392005,0.185822660795616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48197,0.00905019024633213,0.014540583733427,-0.0194493538711847,0.037549734363849,0.533680429079174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48098,0.00935554633620835,0.0188633084678655,-0.0276165382608081,0.0463276309332248,0.619924663171815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48250,0.000553964239874144,0.0128166196095154,-0.024566610194776,0.0256745386745243,0.965524752980265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48235,-0.00481161507585955,0.0119205889909761,-0.0281759694981727,0.0185527393464536,0.68648270687967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#9.Illnesses of father_Diabetes,48121,0.000149095706315039,0.0170054541654583,-0.0331815944579833,0.0334797858706134,0.993004710984762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49624,0.0181826407916401,0.0103096955298607,-0.00202436244688686,0.038389644030167,0.0778067467661456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49469,-0.00211464185299832,0.013405802306206,-0.028390014373162,0.0241607306671654,0.874662627522231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49380,-0.0112182872983828,0.0297176198157087,-0.0694648221371718,0.0470282475404062,0.705808887947164
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49406,0.0501540386475128,0.0185925612037961,0.0137126186880725,0.0865954586069532,0.00699134107511351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#2.Illnesses of mother_Stroke,49561,0.00160698996281219,0.0112946127797107,-0.0205304510854207,0.0237444310110451,0.886860778359766
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49426,-0.00861554213328236,0.0216585519819289,-0.0510663040178631,0.0338352197512983,0.690789637362942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49412,-0.00969795065914957,0.0182688182114281,-0.0455048343535487,0.0261089330352496,0.595530512567777
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49416,-0.00705220807251762,0.0160951697600414,-0.0385987408021988,0.0244943246571635,0.661277302495556
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49458,-0.00420719661647169,0.0180922691260185,-0.039668044103468,0.0312536508705247,0.816120097805985
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49602,0.0113610051986097,0.010043384440639,-0.00832402830504269,0.0310460387022621,0.257987201025479
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49473,0.0437489905441994,0.0154024783707725,0.0135601329374853,0.0739378481509135,0.00451037803296349
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45884,0.0272730074411746,0.0129547060910143,0.00188178350278649,0.0526642313795626,0.0352837006054063
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45710,0.0516727353234354,0.0451649340172031,-0.0368505353502828,0.140196005997154,0.252603024180537
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45702,0.0416984529045149,0.0481032603982382,-0.052583937476032,0.135980843285062,0.386035188139554
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45732,-0.0190957538649212,0.0197767217197044,-0.0578581284355418,0.0196666207056994,0.334274912378958
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45727,0.0231664436768118,0.026681555937317,-0.0291294059603295,0.0754622933139531,0.385266342000665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45760,-0.00211401634141625,0.0216315330531858,-0.0445118211256604,0.0402837884428279,0.922149100849092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45723,0.0173034551947006,0.0240284741304523,-0.0297923541009859,0.0643992644903872,0.471459493317368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45716,0.0381698108873041,0.0244304492835115,-0.00971386970837845,0.0860534914829867,0.118216053014961
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45739,-0.042473285928307,0.0198484489125298,-0.0813762457968654,-0.00357032605974852,0.032379101659988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45755,0.0289069897609838,0.0233157344555387,-0.0167918497718721,0.0746058292938398,0.21506468922488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,45923,-0.000246491251485832,0.010888601491924,-0.0215881501756568,0.0210951676726852,0.981939661591529
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45820,0.0393287835742147,0.0150032931271661,0.0099223290449691,0.0687352381034603,0.00876637208916299
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20127.Neuroticism score,47038,0.0300520019209973,0.0212271061429201,-0.0115531261191261,0.0716571299611207,0.156869952730604
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36617,-0.0030936536123266,0.0339245793416825,-0.0695858291220244,0.0633985218973712,0.927342416795083
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X20161.Pack years of smoking,36890,0.0442012961804181,0.00739929368250273,0.0296986805627127,0.0587039117981234,2.42221598219048e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36890,0.04600501553598,0.00764533703332724,0.0310201549506587,0.0609898761213014,1.85361728305722e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20191.Fluid intelligence score,34261,-0.0201477604963804,0.0403750330767932,-0.0992828253268951,0.0589873043341342,0.617790298375403
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34262,-0.0128341988563918,0.0411706822722506,-0.0935287361100029,0.0678603383972194,0.75525743401287
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20240.Maximum digits remembered correctly,33628,-0.114267135982756,0.0444121385100449,-0.201314927462444,-0.0272193445030684,0.0101178845045981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20255.Spirometry QC measure,45978,0.0526584866631712,0.0267909512448806,0.000148222223205097,0.105168751103137,0.0493690930231305
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X20261.avMSE,34259,-0.00135234537776473,0.00839365129114071,-0.0178039019084005,0.0150992111528711,0.872009040855938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X20262.Myopia diagnosis,34259,0.0332473911529046,0.0517622531010045,-0.0682066249250643,0.134701407230874,0.520701270089017
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X20280.Glucose-lactate,42324,0.0146056497166638,0.00542714517918014,0.00396844516547076,0.0252428542678569,0.00712810765830762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X20281.Spectrometer-corrected alanine,42351,0.0223479402610723,0.0055907497014335,0.0113900708462627,0.033305809675882,6.44169000968113e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36277,-0.0147567309062917,0.0356868003868872,-0.0847028596645905,0.0551893978520071,0.679247936525407
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36277,-0.119964321977523,0.0670196548859836,-0.251322845554051,0.011394201599005,0.073498675577926
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36277,0.0197064281710911,0.116705681730858,-0.209036708021391,0.248449564363573,0.865914908717844
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36277,-0.0671957299457584,0.0327629847406758,-0.131411180037483,-0.00298027985403393,0.0403070799463918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36277,0.0266367313129763,0.0684421878821008,-0.107509956935941,0.160783419561894,0.697150366998296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36280,0.0549939979843294,0.0864478056289301,-0.114443701048374,0.224431697017032,0.52469749801575
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36280,0.0116671871130298,0.0532346398681592,-0.0926727070285622,0.116007081254622,0.826527578291798
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36280,-0.0560198185829312,0.0654918195535767,-0.184383784907941,0.0723441477420791,0.392374583162298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36280,-0.032326598618387,0.0993696248890194,-0.227091063400865,0.162437866164091,0.744950996343958
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36280,0.101698038955028,0.116640415271903,-0.126917174977902,0.330313252887957,0.383295931268777
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36280,-0.102150011826829,0.0693148883726701,-0.238007193037263,0.033707169383604,0.140604235133437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36280,-0.022747999393561,0.123137376264194,-0.264097256871381,0.218601258084259,0.853440802212088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36280,-0.0135349633551913,0.0864790387652344,-0.183033879335051,0.155963952624668,0.875634320527575
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36279,0.155045947285026,0.11866172319645,-0.0775310301800153,0.387622924750068,0.191383734717092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36279,-0.0720888866195716,0.0443683600962986,-0.159050872408317,0.0148730991691736,0.104253624241005
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36279,0.0871737072530405,0.0813247569331618,-0.0722228163359566,0.246570230842038,0.283792069352245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36281,-0.00462462762178726,0.137137466009496,-0.273414061000399,0.264164805756824,0.973099331648679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20600.Liking for adding salt to foods,36114,0.00782777770475213,0.0350165758423638,-0.0608047109462809,0.0764602663557852,0.823118032365111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20601.Liking for aniseed,36114,-0.0489613058734234,0.0343018131407295,-0.116192859629253,0.0182702478824064,0.153519067918488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20602.Liking for apple juice,36114,0.0642902803554816,0.0349020168018584,-0.0041176725761608,0.132698233287124,0.0655147594200942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20603.Liking for apples,36114,-0.0337110074999524,0.0360120215326746,-0.104294569703995,0.0368725547040898,0.349252208229679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20604.Liking for asparagus,36114,-0.0696141686428133,0.035107740106891,-0.13842533925232,-0.000802998033306898,0.0474212116639354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20605.Liking for aubergine,36114,-0.154522861570877,0.0351402250922779,-0.223397702751741,-0.085648020390012,1.11237097528463e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20606.Liking for avocados,36114,-0.121621412646995,0.0354574708209993,-0.191118055456154,-0.0521247698378366,0.000606966749213856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20607.Liking for bacon,36114,0.0635645235047417,0.0350650561526959,-0.00516298655454223,0.132292033564026,0.0699122488716611
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20608.Liking for baked or steamed fish,36114,-0.0267470145671121,0.0354595964233913,-0.0962478235569591,0.0427537944227349,0.450697494393666
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20609.Liking for bananas,36114,0.0360986863225911,0.0364567547436965,-0.035356552975054,0.107553925620236,0.322121657643571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36114,-0.0716854467581409,0.0348125617407996,-0.139918067770108,-0.00345282574617373,0.0395140621602912
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20611.Liking for beef steak,36114,-0.0290566573365551,0.0352820758152576,-0.0982095259344599,0.0400962112613498,0.410222041724931
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20612.Liking for beetroot,36114,-0.00978087028411791,0.0355277191327526,-0.079415199784313,0.0598534592160772,0.783092065768511
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20613.Liking for bell pepper,36114,-0.0911918881505088,0.0349911126927301,-0.15977446902826,-0.0226093072727578,0.00917643620307222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20614.Liking for bicycling,36114,-0.0494377617700304,0.0350826391528403,-0.118199734509597,0.0193242109695367,0.158826872494883
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20615.Liking for biscuits,36114,0.140352347889735,0.0353789501393384,0.0710096056166314,0.209695090162838,7.34835602472727e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20616.Liking for bitter foods,36114,-0.121097241037856,0.035006528809851,-0.189710037505164,-0.0524844445705485,0.00054489915336291
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20617.Liking for bitter or ale,36114,-0.171113193507606,0.0360945877047569,-0.241858585408929,-0.100367801606282,2.17258742974521e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20618.Liking for black olives,36114,-0.147915538645593,0.0352058095848722,-0.216918925431942,-0.0789121518592434,2.68544692296806e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20619.Liking for black pepper,36114,-0.0839159291268013,0.0350839116500423,-0.152680395960884,-0.0151514622927184,0.0167896395451164
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20620.Liking for blue cheese,36114,-0.083076006530595,0.0348871388016374,-0.151454798581804,-0.0146972144793857,0.017279566419921
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20621.Liking for bolognese sauce,36114,-0.0437207150692732,0.0349165219489031,-0.112157098089123,0.0247156679505768,0.210557666939283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20622.Liking for broad beans,36114,-0.0109562818530635,0.0350097102533068,-0.0795753139495449,0.0576627502434179,0.754328243974107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20623.Liking for broccoli,36114,-0.0940531862558373,0.0356322461628861,-0.163892388735094,-0.0242139837765806,0.00832019619539816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20624.Liking for brown rice,36114,-0.00755608548857313,0.0349424846829086,-0.076043355467074,0.0609311844899278,0.828804322912207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20625.Liking for brussel sprouts,36114,-0.0230451440169744,0.0353133638712151,-0.092259337204556,0.0461690491706073,0.514042414803229
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20626.Liking for burgers (meat),36114,-0.00280036561592904,0.0348918333650477,-0.0711883590114225,0.0655876277795644,0.936034001265808
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20627.Liking for burn of spicy foods,36114,-0.0832148901093704,0.0350390520780451,-0.151891432182339,-0.014538348036402,0.0175799637968248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20628.Liking for butter on bread,36114,0.0749458073436788,0.0356134999132021,0.0051433475138028,0.144748267173555,0.0353777346381217
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20629.Liking for butternut squash,36114,-0.116535765705266,0.0347037826565364,-0.184555179712077,-0.0485163516984544,0.000789290428937295
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20630.Liking for cabbage,36114,-0.0310771314109628,0.0352248795836829,-0.100117895394981,0.0379636325730557,0.377672598501488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20631.Liking for cake,36114,0.164928047488339,0.034999720932771,0.0963285944601081,0.233527500516571,2.49768504240216e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20632.Liking for cake icing,36114,0.160946870775871,0.034422231984649,0.0934792960859589,0.228414445465783,2.98562883962502e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20633.Liking for capers,36114,-0.14517721660342,0.035368534907363,-0.214499545021852,-0.0758548881849888,4.09500533538624e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20634.Liking for cauliflower,36114,-0.0433537741219812,0.0351407293252249,-0.112229603599422,0.0255220553554597,0.217349706402108
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20635.Liking for cereal or granola bar,36114,0.010912498577391,0.0346699779675237,-0.0570406582389555,0.0788656553937375,0.752958285518757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20636.Liking for cheesecake,36114,0.141312653636903,0.0348423927177054,0.0730215639102008,0.209603743363606,5.05194098350628e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20637.Liking for cherries,36114,0.00259882936996777,0.0372748380919887,-0.0704598532903302,0.0756575120302657,0.944417949395148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20638.Liking for chicken,36114,0.000395370703151595,0.0366997454929556,-0.0715361304630414,0.0723268718693446,0.991404772385423
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20639.Liking for chilli pepper,36114,-0.142231081204018,0.0347014966276191,-0.210246014594152,-0.0742161478138849,4.20230215267742e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20640.Liking for chips or french fries,36114,0.0220501791060171,0.0352158847454857,-0.046972954995135,0.0910733132071691,0.531241840408107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20641.Liking for cigarette smoking,36114,0.0913136416357247,0.0602074280264709,-0.0266929172961583,0.209320200567608,0.129400618802269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20642.Liking for cod,36114,-0.00639670440697732,0.0360123960568746,-0.0769810006784515,0.0641875918644969,0.859022639462989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20643.Liking for coffee with sugar,36114,0.160046398685885,0.0379781219535701,0.0856092796568878,0.234483517714882,2.53885342216836e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20644.Liking for coffee without sugar,36114,-0.0911616109555339,0.0354354391451551,-0.160615071680038,-0.0217081502310299,0.0101141322510495
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20645.Liking for coriander,36114,-0.137403995780172,0.0349332798844671,-0.205873224353727,-0.0689347672066162,8.45983051805097e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20646.Liking for corn flakes,36114,0.172894543702781,0.0344049091848313,0.105460921700512,0.240328165705051,5.15307662645709e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20647.Liking for cream,36114,0.0831246230052619,0.0348984046772852,0.0147237498377829,0.151525496172741,0.0172503225514413
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20648.Liking for croissant,36114,0.0114600636878094,0.0345980645460364,-0.056352142822422,0.0792722701980409,0.740477600018936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20649.Liking for cucumber,36114,-0.063297707460558,0.03503941579727,-0.131974962423207,0.0053795475020911,0.0708881967283272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20650.Liking for curry,36114,-0.0689800545263307,0.0351412714435763,-0.13785694655574,-0.000103162496921175,0.0496937011267942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20651.Liking for dairy products,36114,0.0997140782297575,0.0358535700473909,0.0294410809368713,0.169987075522644,0.00543137923527984
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20652.Liking for dark chocolate,36114,-0.0312899860032459,0.0354634595163965,-0.100798366655383,0.0382183946488913,0.37763650747686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20653.Liking for diet fizzy drinks,36114,0.100460197048051,0.0363738059063796,0.0291675374715468,0.171752856624555,0.00576208824016088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20654.Liking for dried fruit,36114,0.0526770811159608,0.0352161208631918,-0.0163465157758951,0.121700678007817,0.134745465694515
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20655.Liking for eggs,36114,0.0793887276215016,0.036423476416274,0.00799871384560465,0.150778741397399,0.0293205271932942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20656.Liking for exercising alone,36114,-0.11647031088348,0.0349286420185751,-0.184930449239887,-0.0480101725270729,0.000858961135698384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20657.Liking for exercising with others,36114,-0.0338325342956673,0.0347937105501566,-0.102028206973974,0.0343631383826397,0.330898055588459
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20658.Liking for extra virgin olive oil,36114,-0.118478712961153,0.0353944652422167,-0.187851864835898,-0.0491055610864087,0.000820150715990286
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20659.Liking for fatty foods,36114,0.0668665705854109,0.0352086576771498,-0.00214239846180278,0.135875539632624,0.0575861777556651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20660.Liking for fresh tomatoes,36114,-0.0381607659885213,0.0374490898714393,-0.111560982136542,0.0352394501594998,0.308236818492475
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20661.Liking for fried chicken,36114,0.0228655423858953,0.0350775200116701,-0.0458863968369782,0.0916174816087688,0.514514819996454
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20662.Liking for fried or battered fish,36114,0.0385507684748633,0.0352010415658086,-0.0304432729941214,0.107544809943848,0.273484763070467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20663.Liking for fruit,36114,-0.00295734887300664,0.0398472558084025,-0.0810579702574755,0.0751432725114623,0.940839765452397
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20664.Liking for garlic,36114,-0.130308944882296,0.0352100518796443,-0.199320646566399,-0.0612972431981933,0.000216504907031776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20665.Liking for gherkins,36114,-0.0883221948529594,0.0349519572519075,-0.156828031066698,-0.0198163586392208,0.0115275884269293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20666.Liking for globe artichoke,36114,-0.151061826596988,0.0357399170071578,-0.221112063931018,-0.0810115892629588,2.4019880465061e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20667.Liking for goat's cheese,36114,-0.113414212552357,0.0349267857936669,-0.181870712707944,-0.0449577123967701,0.00117103109190058
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20668.Liking for going to a cafe,36114,0.0845100211608187,0.0352668141872072,0.0153870653538926,0.153632976967745,0.0165877484503702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20669.Liking for going to the gym,36114,-0.0252378636505108,0.0347162003009978,-0.0932816162404665,0.0428058889394449,0.467264942439321
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20670.Liking for going to the pub,36114,-0.114769994421891,0.0348978201143257,-0.18316972184597,-0.0463702669978128,0.00101138862151456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20671.Liking for grapefruit,36114,-0.0629965270522031,0.0346662801267225,-0.130942436100579,0.00494938199617287,0.0692255321455597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20672.Liking for green olives,36114,-0.126634980776316,0.0351481409254361,-0.195525336990171,-0.0577446245624613,0.000316907343514177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20673.Liking for haddock,36114,-0.0215524585751689,0.0361280092804279,-0.0923633567648076,0.0492584396144697,0.550821955661603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20674.Liking for ham,36114,0.0573783468801494,0.0348020581007368,-0.0108336869972948,0.125590380757594,0.0992534218129148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20675.Liking for hard cheese,36114,-0.0284985207585933,0.0355174925768255,-0.0981128062091712,0.0411157646919846,0.422360849221745
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20676.Liking for herring,36114,-0.027100759176842,0.0348445653958808,-0.0953961073527683,0.0411945889990843,0.436736290830618
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20677.Liking for honey,36114,0.0496226550830783,0.034842730943335,-0.0186690975658584,0.117914407732015,0.154436743547676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20678.Liking for horseradish or wasabi,36114,-0.109965667024929,0.0350221631928063,-0.178609106882829,-0.0413222271670284,0.00169724884043491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20679.Liking for ice cream,36114,0.100279573967679,0.0355052304577726,0.0306893222704447,0.169869825664913,0.00475107285007167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20680.Liking for jam,36114,0.133490463810955,0.0346958655856113,0.0654865672631573,0.201494360358753,0.000120430123625468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20681.Liking for kiwi fruit,36114,0.000210804104146849,0.034678299854351,-0.067758663610381,0.0681802718186747,0.995149986577386
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20682.Liking for lager,36114,-0.104342704577822,0.0353595949040464,-0.173647510589753,-0.0350378985658907,0.00317911211111712
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20683.Liking for lamb,36114,0.0668121650761234,0.0358580689291191,-0.00346965002495017,0.137093980177197,0.0624709852388583
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20684.Liking for lemons,36114,-0.107854308480194,0.034996359199242,-0.176447172510708,-0.0392614444496793,0.00206512707018552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20685.Liking for lentils or beans,36114,-0.0527221754577459,0.0351071663374637,-0.121532221479175,0.016087870563683,0.133207457344199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20686.Liking for liver,36114,0.039766645504949,0.034964946062153,-0.0287646487768708,0.108297939786769,0.255440225453216
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20687.Liking for mackerel,36114,-0.0184421327154237,0.0349582149765006,-0.0869602340693648,0.0500759686385174,0.597830101083981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20688.Liking for marzipan,36114,0.0811558225830077,0.0348287633678451,0.0128914463820314,0.149420198783984,0.0198275033828876
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20689.Liking for mayonnaise,36114,-0.0613772087192786,0.0347188984180223,-0.129426249618602,0.00667183218004513,0.0771329694041274
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20690.Liking for melon,36114,0.045832531234885,0.0358439243895671,-0.0244215605686666,0.116086623038437,0.20105641703059
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20691.Liking for milk chocolate,36114,0.111289931901719,0.034788690604642,0.0431040983166208,0.179475765486817,0.00138515254073832
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20692.Liking for mushrooms,36114,0.0198140818521082,0.0361167159722101,-0.0509746814534237,0.0906028451576401,0.583289127277367
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20694.Liking for orange juice,36114,0.0686999859217624,0.0346710954802025,0.000744638780565549,0.136655333062959,0.0475773451504456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20695.Liking for oranges,36114,0.00911465542814031,0.0357331825883984,-0.0609223824451206,0.0791516933014012,0.798672462838592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20696.Liking for pasta,36114,-0.0161648451802637,0.0352746829002158,-0.0853032236646867,0.0529735333041592,0.646782734542244
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20697.Liking for pears,36114,0.0574090103905873,0.0361082066327737,-0.0133630746096492,0.128181095390824,0.111899512706317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20698.Liking for pizza,36114,-0.0239647623583246,0.0350290879426495,-0.0926217747259176,0.0446922500092683,0.493910387169267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20699.Liking for plain yogurt,36114,-0.0427660427618802,0.0351166577953112,-0.11159469204069,0.0260626065169298,0.223330987322978
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20700.Liking for plums,36114,0.00944151736831438,0.0356846705155057,-0.0605004368420767,0.0793834715787055,0.791339467071756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20701.Liking for pollock,36114,-0.0218827694888321,0.0347845043429156,-0.0900603980009466,0.0462948590232824,0.529307435928894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20702.Liking for pork chop,36114,0.0313072597575438,0.0347706382455909,-0.0368431912038144,0.0994577107189019,0.367942204865184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20703.Liking for porridge,36114,0.0364895228155967,0.0357673179559347,-0.0336144203780354,0.106593466009229,0.307673238707847
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20704.Liking for potato crisps,36114,0.0312317042752921,0.0346373010029138,-0.0366574056904189,0.0991208142410031,0.367259181161623
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20705.Liking for potatoes,36114,0.053106949336034,0.0356142503809394,-0.0166969814106071,0.122910880082675,0.135962150647327
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20706.Liking for prawns,36114,-0.0489636693220636,0.0353059288164992,-0.118163289802402,0.0202359511582749,0.165535328396764
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20707.Liking for raw carrots,36114,-0.0388127055080998,0.0354797613032915,-0.108353037662551,0.0307276266463516,0.274019724195734
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20708.Liking for red meat,36114,-0.0593291686240231,0.0352170087287369,-0.128354505732347,0.00969616848430124,0.0920966944130156
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20709.Liking for red wine,36114,-0.203057627853908,0.035488359369437,-0.272614812218004,-0.133500443489811,1.09804924328593e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36114,0.127081787761636,0.0360135173984574,0.0564952936606596,0.197668281862613,0.000420282172378607
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20711.Liking for roast chicken,36114,0.00379107561773792,0.0367966967194993,-0.0683304499524807,0.0759126011879565,0.917944049394172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20712.Liking for salad dressing,36114,-0.0413251026629583,0.0346353519799182,-0.109210392543598,0.0265601872176814,0.232852354969971
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20713.Liking for salad leaves,36114,-0.101114390877932,0.0354075012847991,-0.170513093396138,-0.0317156883597261,0.00430655106557754
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20714.Liking for salami,36114,-0.0724080787372101,0.0354133095369928,-0.141818165429716,-0.0029979920447042,0.0409264714347218
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20715.Liking for salmon,36114,-0.0227474820493467,0.0367906523782506,-0.0948571607107179,0.0493621966120245,0.536401171810445
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20716.Liking for salty foods,36114,0.0428640791878129,0.0348935632946281,-0.0255273048696582,0.111255463245284,0.219329796375446
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20717.Liking for salty pretzels,36114,-0.0289567310451541,0.0348018907450149,-0.0971684369053832,0.039254974815075,0.405412425461495
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20718.Liking for sardines,36114,-0.0448760911734504,0.0351639958076367,-0.113797522956418,0.0240453406095176,0.201929727339447
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20719.Liking for sausages (meat),36114,0.0134640852895888,0.0352591622743829,-0.0556438727682017,0.0825720433473794,0.702576497769852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20720.Liking for savoury biscuits,36114,0.0858253888624146,0.0353133063393042,0.0166113084373784,0.155039469287451,0.0151075306230658
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36114,-0.128652440209692,0.0344343777366317,-0.19614382057349,-0.061161059845894,0.000188355315629566
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20722.Liking for skimmed milk,36114,0.0404290196335434,0.0344706559044481,-0.0271334659391749,0.107991505206262,0.240895096727893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20723.Liking for smoked fish,36114,-0.0336773461128809,0.0349625790453669,-0.1022040010418,0.0348493088160382,0.335460919838825
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20724.Liking for soft cheese,36114,-0.0230495486325337,0.0345352083771579,-0.0907385570517633,0.0446394597866958,0.504525072026373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20725.Liking for soy sauce,36114,-0.0729135925352804,0.0349323001406894,-0.141380900811032,-0.00444628425952913,0.0368991135992682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20726.Liking for soya milk,36114,-0.0193761225580792,0.0355479476700207,-0.0890500999913198,0.0502978548751614,0.585722911098679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20727.Liking for spicy foods,36114,-0.126333975613909,0.0350933815195287,-0.195117003392185,-0.0575509478356326,0.000320524149157494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20728.Liking for spinach,36114,-0.0992154584421192,0.0350682281050879,-0.167949185528092,-0.0304817313561469,0.00467972188596245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20729.Liking for spirits,36114,-0.119649318834488,0.03498795708361,-0.188225714718363,-0.051072922950612,0.000630461154594225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20730.Liking for strawberries,36114,0.0180524404898978,0.0387542367051315,-0.05790586345216,0.0940107444319555,0.641360099952926
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36114,0.167212001745154,0.0356710073201339,0.0972968273976911,0.237127176092616,2.8170462088567e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20732.Liking for sweet foods,36114,0.205877395963637,0.035027556668207,0.137223384893951,0.274531407033323,4.35673735319028e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20733.Liking for taking the stairs,36114,-0.110122571697152,0.03576939039801,-0.180230576877252,-0.0400145665170526,0.00208733846184602
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20734.Liking for tea with sugar,36114,0.128894386929601,0.042252276179991,0.0460799256168184,0.211708848242383,0.00229257841024619
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20735.Liking for tea without sugar,36114,-0.0553874083546099,0.036084269198022,-0.126112575982733,0.0153377592735131,0.124842843957215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20736.Liking for tomato ketchup,36114,0.0535117213749277,0.034948771778011,-0.0149878713099739,0.122011314059829,0.125778735036434
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20737.Liking for tinned tuna,36114,-0.0471249213465752,0.0350118524177466,-0.115748152085358,0.0214983093922081,0.178356172314272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20738.Liking for turnip (white),36114,0.0734584005326581,0.0346370597733237,0.00556976337694354,0.141347037688373,0.033973848375608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20739.Liking for vegetables,36114,-0.0826997229148417,0.0385048544165608,-0.158169237571301,-0.00723020825838244,0.031766382848634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20740.Liking for vinegar,36114,-0.0381809721003463,0.034859378012601,-0.106505353005044,0.0301434088043516,0.273429735904238
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20741.Liking for watching television,36114,0.033438457086677,0.0353169208466767,-0.0357827077728092,0.102659621946163,0.343768083897989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20742.Liking for whisky,36114,-0.105906116691683,0.036263994355273,-0.176983545628018,-0.0348286877553482,0.00350689471630146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20743.Liking for white bread,36114,0.10803431752291,0.0347953218432089,0.0398354867102209,0.1762331483356,0.00191144389762653
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20744.Liking for white rice,36114,0.0218285720422743,0.035033809872814,-0.0468376953084412,0.0904948393929898,0.533258030241578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20745.Liking for white wine,36114,-0.222006727523362,0.034768692855194,-0.290153365519542,-0.153860089527182,1.8221229262988e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36114,-0.0116539302120931,0.0351422682898342,-0.0805327760601681,0.0572249156359819,0.740185170824871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20747.Liking for whole milk,36114,0.111454664011836,0.0348222730114041,0.0432030089094839,0.179706319114188,0.00137727887740152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20748.Liking for wholemeal bread,36114,-0.0762272406762128,0.0367700124362689,-0.1482964650513,-0.00415801630112572,0.0382016452974671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20749.Liking for working up a sweat,36114,-0.111893776628844,0.035282670488384,-0.181047810786077,-0.0427397424716117,0.00152394510391937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21001.Body mass index (BMI),51813,0.0913515033345413,0.0195091026443705,0.0531136621515752,0.129589344517507,2.85032523048615e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21002.Weight,51832,-0.00229056174142998,0.0104778715974634,-0.0228271900724583,0.0182460665895984,0.826956261868591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21021.Pulse wave Arterial Stiffness index,36936,0.0174533605989157,0.00691967441989702,0.00389079873591756,0.0310159224619139,0.0116795488237118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,35920,0.0520735340476036,0.0377139490940992,-0.0218458061768309,0.125992874272038,0.167401763396939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,35936,-0.0749347101991381,0.0384661037454209,-0.150328273540163,0.00045885314188697,0.0514479002524787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,35938,-0.0594461133257799,0.0380290266700469,-0.133983005599072,0.0150907789475121,0.118057825890668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21040.Satisfaction with bowel habits,35895,0.050735130905979,0.0349102074359802,-0.0176888756685421,0.1191591374805,0.146186362524128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,35876,0.0720775667941998,0.0376345288064623,-0.00168610966646625,0.145841243254866,0.0555099829415815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21042.Greatest number of times bowels opened per day,35897,0.0219880021964014,0.0375645897283994,-0.0516385936712613,0.0956145980640641,0.55833981112203
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21043.Least number of times bowels opened per week,35829,-0.0316202431205005,0.0379445301297372,-0.105991522174785,0.0427510359337843,0.404689714835167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21044.Average number of times bowels opened per day,35862,-0.0228035559084084,0.0427553443249202,-0.106604030785252,0.0609969189684352,0.593809232724592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,35942,-0.0277231990746091,0.0384945493457125,-0.103172515792206,0.0477261176429873,0.471436013367941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,35937,0.00752532801877452,0.0386396381188456,-0.0682083626941628,0.0832590187317118,0.845589297649432
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32737,0.0472537710918817,0.0681454806762116,-0.0863113710334931,0.180818913217256,0.488088426864882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,35940,0.0147282965079689,0.0441956782033886,-0.0718952327706728,0.101351825786611,0.738954455116104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,35940,-0.0707171022890384,0.0572274816794498,-0.18288296638076,0.0414487618026831,0.216605964511986
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,35939,-0.104672106625352,0.0440926256271218,-0.191093652854511,-0.0182505603961934,0.0176284847635805
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,35939,-0.0460659044163311,0.110585237985019,-0.262812970866969,0.170681162034307,0.677010104548225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,35943,0.0308561056375836,0.0455331642798476,-0.0583888963509177,0.120101107626085,0.498009112857448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,35940,-0.135171561355457,0.0414109779035499,-0.216337078046415,-0.0540060446644989,0.00110341028390389
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,35787,0.0373652709233187,0.0399406332047566,-0.0409183701580043,0.115648912004642,0.349554529622406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,35935,-0.0198873160950401,0.0386332850696083,-0.0956085548314723,0.0558339226413921,0.606729547000425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,35940,-0.01908389663289,0.0615336545859948,-0.13968985962144,0.10152206635566,0.756465942992579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,35944,-0.1168454357018,0.038914230329438,-0.193117327147499,-0.0405735442561018,0.00268629174857418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,35943,0.0160494044971388,0.0387951101724763,-0.0599890114409148,0.0920878204351924,0.679109477152421
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X21100.Water hardness (USGS classification),51782,-0.0073243372131814,0.019862677119953,-0.0462551843682893,0.0316065099419265,0.712318469960646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2139.Age first had sexual intercourse,48046,-0.005497439526722,0.00479249884994606,-0.0148907372726163,0.00389585821917228,0.251357947532101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2149.Lifetime number of sexual partners,46869,-0.0704461803648583,0.0230064958229833,-0.115538912177906,-0.0253534485518111,0.00220184407921061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22032.IPAQ activity group,46888,-0.118704703207286,0.0230783851283769,-0.163938338058905,-0.0734710683556674,2.72480026942564e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22033.Summed days activity,47391,-0.0250268744138851,0.00465147091970172,-0.0341437574165004,-0.0159099914112697,7.52301872037583e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22034.Summed minutes activity,46888,-0.0233083283427976,0.00460309720685358,-0.0323303988682306,-0.0142862578173646,4.15503887349693e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22037.MET minutes per week for walking,45918,-0.0158433265615093,0.00492712449786067,-0.0255004905773162,-0.00618616254570236,0.0013045037478849
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22038.MET minutes per week for moderate activity,46888,-0.0184372326713225,0.00449306187623264,-0.0272436339487384,-0.00963083139390647,4.08787855515874e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22039.MET minutes per week for vigorous activity,46888,-0.131454927387921,0.0232238306323706,-0.176973635427367,-0.0859362193484742,1.53409173406831e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22040.Summed MET minutes per week for all activity,45918,-0.0237959580951143,0.00477937088737607,-0.0331635250343714,-0.0144283911558572,6.45868981970884e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X2217.Age started wearing glasses or contact lenses,49970,-0.00709703266488429,0.00392329640319583,-0.0147866936151481,0.000592628285379547,0.0704737893905016
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X22501.Year ended full time education,34042,-0.0547234498716522,0.0199379106328514,-0.093801754712041,-0.0156451450312634,0.00607905489390549
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X22506.Tobacco smoking,34010,-0.0950659365581673,0.0879609631986328,-0.267469424427488,0.077337551311153,0.279851722822232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50628,-0.0116573031543805,0.0758917393247607,-0.160405112230912,0.137090505922151,0.877923133581241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23098.Weight,51348,-0.00193450853278664,0.0105972989479757,-0.0227052144708191,0.0188361974052458,0.855154891709075
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23099.Body fat percentage,51340,0.0581704195355064,0.0100745946738978,0.0384242139746668,0.077916625096346,7.84595408202227e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23100.Whole body fat mass,51325,0.0479268576936169,0.00994070509423528,0.0284430757089157,0.067410639678318,1.4359149297027e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23101.Whole body fat-free mass,51347,-0.027470572030047,0.00862114273127304,-0.0443680117833421,-0.0105731322767518,0.00144245661846111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23102.Whole body water mass,51348,-0.0287286921089121,0.00864869426221544,-0.0456801328628544,-0.0117772513549699,0.000896034950968199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23104.Body mass index (BMI),51348,0.093047851520351,0.0195466312099251,0.0547364543488978,0.131359248691804,1.94524688736084e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23105.Basal metabolic rate,51348,-0.0247766742159986,0.00921091271977029,-0.0428300631467484,-0.00672328528524881,0.00715213969804493
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23106.Impedance of whole body,51345,0.0342552226929636,0.0070454704085679,0.0204461006921705,0.0480643446937567,1.16989493613202e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23107.Impedance of leg (right),51348,0.0265001837027748,0.00567757915315795,0.0153721285625852,0.0376282388429644,3.06649337002719e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23108.Impedance of leg (left),51348,0.0237750559951339,0.0056432396248235,0.0127143063304799,0.034835805659788,2.52980058312936e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23109.Impedance of arm (right),51345,0.0188490648687795,0.00695897982242272,0.00520946441683092,0.032488665320728,0.00676204651433315
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23110.Impedance of arm (left),51348,0.0207559097841313,0.00698757099762132,0.00706027062879352,0.0344515489394691,0.00297727122661136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23111.Leg fat percentage (right),51348,0.0557985439010871,0.0118234059765174,0.0326246681871129,0.0789724196150612,2.38068722963695e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23112.Leg fat mass (right),51348,0.0505653230430765,0.012952615905852,0.0251781958676065,0.0759524502185465,9.49470958472223e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23113.Leg fat-free mass (right),51347,-0.0289242760836298,0.0087658361284225,-0.0461053148953379,-0.0117432372719217,0.000969548854237094
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23114.Leg predicted mass (right),51347,-0.0280759009544579,0.00881812612100707,-0.0453594281516318,-0.0107923737572841,0.00145513602930817
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23115.Leg fat percentage (left),51345,0.0504928533045131,0.0124328260168034,0.0261245143115785,0.0748611922974477,4.89778941212873e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23116.Leg fat mass (left),51345,0.0466033793226809,0.0135717557306534,0.0200027380906002,0.0732040205547617,0.000596161317856538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23117.Leg fat-free mass (left),51344,-0.0259384333337202,0.00922948938396191,-0.0440282325262856,-0.00784863414115487,0.00495254313401638
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23118.Leg predicted mass (left),51344,-0.0264405035413142,0.00928656329459952,-0.0446421675987293,-0.00823883948389918,0.00441491777335859
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23119.Arm fat percentage (right),51344,0.0574376405171434,0.011405320767228,0.0350832118133765,0.0797920692209103,4.78993801098845e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23120.Arm fat mass (right),51342,0.0506915076291224,0.0113758346350759,0.0283948717443736,0.0729881435138711,8.38850796110806e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23121.Arm fat-free mass (right),51343,-0.021737402973492,0.00881564276040034,-0.0390160627838767,-0.00445874316310731,0.0136791901122972
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23122.Arm predicted mass (right),51343,-0.0209346700757519,0.00883130923507904,-0.0382440361765068,-0.00362530397499693,0.017772274872494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23123.Arm fat percentage (left),51342,0.0593763304668367,0.0116754026923314,0.0364925411898672,0.0822601197438062,3.69469560652997e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23124.Arm fat mass (left),51342,0.047254249984619,0.0113892121412656,0.0249313941877383,0.0695771057814996,3.35124174853661e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23125.Arm fat-free mass (left),51342,-0.0197509889108437,0.00899397712223902,-0.0373791840704321,-0.00212279375125518,0.0281005616224235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23126.Arm predicted mass (left),51340,-0.0218379610418777,0.00899908800298833,-0.0394761735277348,-0.00419974855602057,0.0152453624270172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23127.Trunk fat percentage,51339,0.0378275278736937,0.0072119395080611,0.023692126437894,0.0519629293094935,1.57611467497901e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23128.Trunk fat mass,51339,0.0349619651972268,0.00806753705563515,0.0191495925681819,0.0507743378262717,1.47296431087988e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23129.Trunk fat-free mass,51338,-0.0257646129741469,0.00777780540687965,-0.041009111571631,-0.0105201143766628,0.000925872956956043
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23130.Trunk predicted mass,51335,-0.0255780884040871,0.00780053304510256,-0.0408671331724881,-0.0102890436356861,0.0010432967060693
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23400.Total Cholesterol,42357,-0.0706359818335253,0.00544865953262606,-0.0813153545174724,-0.0599566091495782,3.35704651204814e-38
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42357,-0.00925516424088026,0.00531523196025661,-0.0196730188829832,0.00116269040122269,0.0816625821160995
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42357,0.00981148910234336,0.00530597976480491,-0.000588231236674262,0.020211209441361,0.0644602864008788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23403.VLDL Cholesterol,42357,0.0757757281585888,0.00534768112839158,0.0652942731469413,0.0862571831702363,3.02829411658649e-45
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23404.Clinical LDL Cholesterol,42357,-0.0305852693716336,0.00530534735734579,-0.0409837501920313,-0.0201867885512358,8.34954287070788e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23405.LDL Cholesterol,42357,-0.0266398552777712,0.00533281620331065,-0.03709217503626,-0.0161875355192823,5.94494099786687e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23406.HDL Cholesterol,42357,-0.230080327821008,0.00578146245303937,-0.241411994228965,-0.218748661413051,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23407.Total Triglycerides,42357,0.131627395661988,0.00570311331943438,0.120449293555897,0.142805497768079,1.42931629302133e-115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23408.Triglycerides in VLDL,42357,0.139259583550874,0.00566614942946336,0.128153930669125,0.150365236432622,1.87454998848003e-130
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23409.Triglycerides in LDL,42357,0.0837464919892143,0.00573092765803708,0.0725138737794616,0.094979110198967,5.50450324634428e-48
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23410.Triglycerides in HDL,42357,0.0714619677110715,0.00566906753987434,0.0603505953329178,0.0825733400892252,3.18399671650237e-36
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42357,-0.0799585823198041,0.00564008306124581,-0.0910131451198459,-0.0689040195197624,2.74443869090553e-45
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23412.Phospholipids in VLDL,42357,0.110269758043127,0.00547424935402662,0.099540229309235,0.120999286777019,6.69116494976106e-89
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23413.Phospholipids in LDL,42357,-0.0165416281325045,0.0053028109726655,-0.0269351376389289,-0.00614811862608013,0.00181606455454314
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23414.Phospholipids in HDL,42357,-0.188314002594809,0.00585069442569058,-0.199781363669163,-0.176846641520456,7.31969248768176e-219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23415.Total Esterified Cholesterol,42357,-0.0824816398830616,0.00546389008583095,-0.0931908644512902,-0.0717724153148329,4.61699574747424e-51
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42357,0.0596039745190586,0.00530135727070935,0.0492133142684683,0.069994634769649,3.3998168061986e-29
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42357,-0.0167273131767208,0.00534244111256629,-0.0271984977573508,-0.00625612859609092,0.00174579026132815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42357,-0.234291881807244,0.00573632573396115,-0.245535080245808,-0.22304868336868,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23419.Total Free Cholesterol,42357,-0.0406114622442899,0.00540815689745887,-0.0512114497633093,-0.0300114747252705,6.32690725343357e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23420.Free Cholesterol in VLDL,42357,0.0964875784329495,0.00542980482625151,0.0858451609734966,0.107129995892402,7.87834037396685e-70
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23421.Free Cholesterol in LDL,42357,-0.0521954662713893,0.00532687098191746,-0.0626361333959475,-0.041754799146831,1.36480846512325e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23422.Free Cholesterol in HDL,42357,-0.203008269410828,0.00592055576295018,-0.21461255870621,-0.191403980115445,7.02753876735058e-247
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42357,-0.0232798098916142,0.00546585716800573,-0.0339928899409054,-0.012566729842323,2.06646788236804e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23424.Total Lipids in VLDL,42357,0.120556277518386,0.00553224604994534,0.109713075260493,0.131399479776279,1.86097004528797e-103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23425.Total Lipids in LDL,42357,-0.0184543765885066,0.00533057766332841,-0.0289023088086303,-0.00800644436838297,0.000537911045084495
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23426.Total Lipids in HDL,42357,-0.204103074980031,0.00584582648610497,-0.215560894892796,-0.192645255067265,1.66861567650957e-255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42357,-0.168965987458011,0.00558243799236522,-0.179907565923046,-0.158024408992975,1.31888556896469e-194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23428.Concentration of VLDL Particles,42357,0.0890485802126248,0.0054311316373926,0.0784035622033353,0.0996935982219143,7.99805499971278e-60
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23429.Concentration of LDL Particles,42357,0.0200307002138606,0.00528285633154374,0.00967630180403482,0.0303850986236863,0.000150322921112853
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23430.Concentration of HDL Particles,42357,-0.181736268244066,0.00556054833997289,-0.192634942990413,-0.17083759349772,2.40709199593391e-225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42357,0.14528304855162,0.00575637547342879,0.134000552623699,0.15656554447954,2.70242745306424e-137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23432.Average Diameter for LDL Particles,42357,-0.0681929071940511,0.00558959888076962,-0.0791485210003596,-0.0572372933877427,4.74788084610343e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23433.Average Diameter for HDL Particles,42357,-0.174924695245211,0.00613553386790412,-0.186950341626303,-0.162899048864119,1.5547650261536e-173
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23434.Phosphoglycerides,42346,-0.0957768121605917,0.0057281006022976,-0.107003889341095,-0.0845497349800884,4.06316028108196e-62
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42346,0.200491744934287,0.00579030044001464,0.189142756071858,0.211840733796715,1.69699424323469e-251
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23436.Total Cholines,42346,-0.107965415525617,0.00571987225665645,-0.119176365148664,-0.0967544659025707,1.96718162735779e-78
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23437.Phosphatidylcholines,42346,-0.112874612594962,0.00575557028318103,-0.124155530349996,-0.101593694839927,1.97840009266535e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23438.Sphingomyelins,42346,-0.104707041917225,0.00562056143706598,-0.115723342333874,-0.0936907415005753,1.78767406261334e-76
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23439.Apolipoprotein B,42357,0.0220928652718828,0.00527995588209429,0.011744151742978,0.0324415788007876,2.87915444761508e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23440.Apolipoprotein A1,42357,-0.195126611828104,0.00571788058452208,-0.206333657773767,-0.183919565882441,1.18289445403044e-244
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42357,0.112707699477486,0.00531626952553781,0.102287811207432,0.12312758774754,4.0903366480872e-98
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23442.Total Fatty Acids,42346,0.0258646755734279,0.00562502030006005,0.0148396357853102,0.0368897153615456,4.30236366386561e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23443.Degree of Unsaturation,42346,-0.129692846338602,0.00561594131402219,-0.140700091314085,-0.118685601363118,1.05677961326979e-115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23444.Omega-3 Fatty Acids,42346,-0.0292606673985453,0.00567796045718666,-0.0403894698946311,-0.0181318649024594,2.59543911543047e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23445.Omega-6 Fatty Acids,42346,-0.0350942349417239,0.00554528987448811,-0.0459630030957206,-0.0242254667877272,2.55330141126199e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42346,-0.0386781531222312,0.00561766921395923,-0.0496887847815913,-0.0276675214628711,6.03730640342854e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42346,0.0837556906890196,0.00572179376261417,0.0725409749142958,0.0949704064637433,3.84113669073771e-48
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23448.Saturated Fatty Acids,42346,0.0290257433594222,0.00562324442178447,0.0180041842927246,0.0400473024261197,2.48227539121729e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23449.Linoleic Acid,42346,-0.0196062227263219,0.00543531636366633,-0.0302594427991079,-0.00895300265353586,0.000310677239248324
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23450.Docosahexaenoic Acid,42346,-0.0927240179943284,0.00561750681777739,-0.103734331357172,-0.0817137046314847,1.34413755239313e-60
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42346,-0.0497889175284282,0.00560856749622149,-0.0607817098210223,-0.0387961252358341,7.72817002547443e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42346,-0.116340833069365,0.00594976744120499,-0.128002377254127,-0.104679288884603,5.92792457231494e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42346,-0.136225207202355,0.0058412629366432,-0.147674082558176,-0.124776331846534,6.56498422837784e-118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42346,0.174787976909288,0.00584343330301945,0.16333484763537,0.186241106183206,3.00161303654056e-190
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42346,0.0251260117331607,0.00547195038545212,0.0144009889776746,0.0358510344886469,4.43548524666298e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42346,-0.079045476340383,0.00576258185467023,-0.0903401367755367,-0.0677508159052294,1.57492953277392e-42
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42346,-0.106895380520049,0.00552917358599295,-0.117732560748595,-0.0960582002915024,3.89598150706145e-82
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42346,-0.166613323715497,0.00587484433541721,-0.178128018612915,-0.155098628818079,8.68754769740498e-172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42346,0.0162443714152928,0.00556432042078027,0.00533830339056351,0.0271504394400222,0.00351322136254846
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23460.Alanine,42351,0.020658581900695,0.00547711823540916,0.00992343015929307,0.031393733642097,0.00016278568008215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23461.Glutamine,42311,-0.0604329079753549,0.00545803628300154,-0.0711306590900379,-0.0497351568606719,2.28363338112525e-28
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23462.Glycine,42341,-0.00778088969889508,0.00583898092451242,-0.0192252923109394,0.00366351291314927,0.182693863717041
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23463.Histidine,42338,0.000826725495916691,0.00540439265857838,-0.00976588411489694,0.0114193351067303,0.878422012329377
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42348,0.0464297528156579,0.00570170006986086,0.0352544206787306,0.0576050849525851,4.19650119010461e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23465.Isoleucine,42353,0.0527604281830445,0.00554544787285391,0.0418913503522508,0.0636295060138381,2.14565782088772e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23466.Leucine,42353,0.0370043825772252,0.00562472950037661,0.025979912756487,0.0480288523979634,4.91961745865315e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23467.Valine,42348,0.0451315158724831,0.0057591131659233,0.0338436540672734,0.0564193776776928,4.98589449498926e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23468.Phenylalanine,42350,0.0316572667232336,0.00545269254590065,0.0209699893332683,0.0423445441131989,6.55361535196146e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23469.Tyrosine,42341,0.0119721470414031,0.00554776126302056,0.00109853496588285,0.0228457591169234,0.030944784921292
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23470.Glucose,42330,0.0051029914745253,0.00539705893575889,-0.00547524403956212,0.0156812269886127,0.344414230674503
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23471.Lactate,42332,0.0166612395642755,0.00543327270455977,0.00601202506333829,0.0273104540652126,0.00217006312809876
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23472.Pyruvate,42315,-0.034011485966422,0.00546498896055278,-0.0447228643291054,-0.0233001076037386,5.00909792474329e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23473.Citrate,42354,0.00900263628339505,0.0054943510158082,-0.00176629170758903,0.0197715642743791,0.101335947093331
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23474.3-Hydroxybutyrate,42136,-0.000196986667676484,0.00575746059860954,-0.0114816094409512,0.0110876361055982,0.972706904186475
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23475.Acetate,42345,-0.026646696700856,0.00538047019443666,-0.0371924182819518,-0.0161009751197601,7.41815062033392e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23476.Acetoacetate,42355,0.0141462949759898,0.00554289221008679,0.00328222624421971,0.0250103637077599,0.0107172225818455
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23477.Acetone,42355,-0.0558770054064237,0.00547732932058028,-0.0666125708747611,-0.0451414399380864,2.4049931426191e-24
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23478.Creatinine,42046,0.0612359587485487,0.00610160299374712,0.0492768168808043,0.073195100616293,1.29291311817454e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23479.Albumin,42355,-0.0804787887710446,0.00544027859566724,-0.0911417348185524,-0.0698158427235368,4.02165718045029e-49
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23480.Glycoprotein Acetyls,42357,0.15639339467625,0.00565044357503913,0.145318525269173,0.167468264083326,6.04007580603547e-164
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42357,0.151723375596701,0.00568775230109611,0.140575381086552,0.162871370106849,1.00210568311483e-152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42357,0.148194236441964,0.00563198531273779,0.137155545228998,0.15923292765493,9.25262322429931e-149
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42357,0.153905114572671,0.00569397031705014,0.142744932751253,0.165065296394089,1.2056037645862e-156
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42357,0.147822931781996,0.00565377553099911,0.136741531741238,0.158904331822755,5.99346757137862e-147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42357,0.145114285456766,0.00559164341263451,0.134154664368003,0.15607390654553,7.35599146463763e-145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42357,0.145874322775715,0.0057103210268966,0.134682093562998,0.157066551988432,1.57881724474589e-140
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42357,0.142010099286261,0.00558504464387364,0.131063411784269,0.152956786788254,2.8457778564449e-139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42357,0.151842426478803,0.00566465236656858,0.140739707840329,0.162945145117278,3.70879830302298e-154
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42357,0.150796348031956,0.0056364095951565,0.139748985225449,0.161843710838463,1.36641292819874e-153
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42357,0.151271179423962,0.00561491337641412,0.140265949206191,0.162276409641734,1.16318403540009e-155
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42357,0.134671552366082,0.00551440646444536,0.123863315695769,0.145479789036395,7.24266195287144e-129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42357,0.120467429266408,0.00545010644129392,0.109785220641472,0.131149637891344,2.47611163887059e-106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42357,0.14580396618188,0.00558113300912197,0.134864945484001,0.156742986879759,1.02180807141741e-146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42357,0.15238998609376,0.00567140278792464,0.141274036629428,0.163505935558092,7.14329901582879e-155
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42357,0.141103973074703,0.00561482846647304,0.130098909280416,0.15210903686899,3.63820967078658e-136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23496.Total Lipids in Large VLDL,42357,0.136886103656299,0.00559067206775337,0.125928386403503,0.147843820909096,1.6565992051342e-129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23497.Phospholipids in Large VLDL,42357,0.146706905723587,0.00560115044278712,0.135728650855724,0.157685160591449,1.88654983037485e-147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23498.Cholesterol in Large VLDL,42357,0.129694453737155,0.00551579561981269,0.118883494322322,0.140505413151987,8.63895542223315e-120
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42357,0.114904074920528,0.0054420038632688,0.104237747348521,0.125570402492534,2.39730609239525e-97
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42357,0.142073276661925,0.00559767769219208,0.131101828385228,0.153044724938621,8.70494833552009e-139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23501.Triglycerides in Large VLDL,42357,0.130635201692433,0.00559856000647667,0.119662024079738,0.141608379305127,4.93432594917128e-118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42357,0.0658645695162878,0.00536420245238455,0.055350732709614,0.0763784063229615,1.82313809696253e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42357,0.0800472269140956,0.00540804732092835,0.0694474541650761,0.0906469996631152,3.55817679210391e-49
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42357,0.0610781516907232,0.00534593336253465,0.0506001223001553,0.0715561810812912,4.33915144527268e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42357,0.0130804062596771,0.00527637466278694,0.00273871192061473,0.0234221005987395,0.0131856445327242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42357,-0.0121944438128074,0.005293243464831,-0.0225692010038761,-0.00181968662173863,0.0212507592751266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42357,0.0462704050050239,0.00531909008502661,0.0358449884383717,0.056695821571676,3.74421544145172e-18
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42357,0.116128799795381,0.00557375392342548,0.105204242105467,0.127053357485295,7.04251869504812e-95
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42357,0.107283980308914,0.00549202899345739,0.0965196034817372,0.11804835713609,8.55076586847466e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23510.Total Lipids in Small VLDL,42357,0.0998536633779232,0.00548597264147971,0.0891011570006229,0.110606169755223,3.94078384831071e-73
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23511.Phospholipids in Small VLDL,42357,0.0686702695102611,0.0053897870553879,0.0581062868817008,0.0792342521388213,5.7968669122495e-37
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23512.Cholesterol in Small VLDL,42357,0.0661597083006618,0.00533818502370331,0.0556968656542033,0.0766225509471203,4.43705869336881e-35
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42357,0.0798125943286999,0.00535132050780172,0.0693240061334085,0.0903011825239913,6.76868264615848e-50
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42357,0.0414874771317667,0.00531898283731552,0.0310622707706283,0.0519126834929051,6.66119453574601e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23515.Triglycerides in Small VLDL,42357,0.126893299036274,0.00566379074822007,0.115792269169763,0.137994328902785,3.87299913408685e-109
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42357,0.0423854368973015,0.00541677576164152,0.0317685564044842,0.0530023173901189,5.46926164199246e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42357,0.0435536649620343,0.00546925558252124,0.0328339240202927,0.0542734059037759,1.81102242526142e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42357,0.0607448848311165,0.00546221610471578,0.0500389412658735,0.0714508283963594,1.33072352499829e-28
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42357,0.000984838065649587,0.00541006332320087,-0.00961888604782412,0.0115885621791233,0.855555568529445
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42357,-0.0136891240233156,0.00541607925742497,-0.0243046393678686,-0.00307360867876271,0.011499486088527
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42357,0.0362528454789082,0.00542938591727194,0.0256112490810552,0.0468944418767612,2.53402977776096e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42357,0.11163656503597,0.00568626023381035,0.100491494977702,0.122781635094239,1.3133206035644e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23523.Concentration of IDL Particles,42357,-0.00991194300512625,0.00526120950459806,-0.0202239136341385,0.000400027623885945,0.0595915133259646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23524.Total Lipids in IDL,42357,-0.0494021758487118,0.00540014748527683,-0.0599864649198544,-0.0388178867775692,6.62362731108182e-20
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23525.Phospholipids in IDL,42357,-0.0385992928770585,0.00541998652459044,-0.0492224664652558,-0.0279761192888613,1.12174751329274e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23526.Cholesterol in IDL,42357,-0.0635763293383399,0.00538642199661993,-0.074133716451715,-0.0530189422249649,5.45499758532226e-32
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42357,-0.0653061672017254,0.00538851408672676,-0.0758676548117098,-0.0547446795917409,1.25730266628975e-33
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23528.Free Cholesterol in IDL,42357,-0.0575329217428421,0.00537812470120668,-0.0680740461572072,-0.046991797328477,1.34358586350862e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23529.Triglycerides in IDL,42357,0.0832551054015672,0.00572542788211244,0.0720332667526269,0.0944769440505076,1.54902644265581e-47
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23530.Concentration of Large LDL Particles,42357,0.011904642892998,0.00528439118407524,0.00154723617221057,0.0222620496137855,0.0242885612615906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23531.Total Lipids in Large LDL,42357,-0.0371703555895227,0.00535537195877681,-0.0476668846287252,-0.0266738265503201,4.08262950291104e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23532.Phospholipids in Large LDL,42357,-0.034811110752047,0.00531704222548462,-0.0452325135139969,-0.0243897079900972,6.08490452651835e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23533.Cholesterol in Large LDL,42357,-0.0451472008248196,0.0053626794465793,-0.0556580525401151,-0.0346363491095242,4.1949483900397e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42357,-0.0376759779920745,0.00536721803106298,-0.048195725332958,-0.0271562306511911,2.33331457125148e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42357,-0.0641040488739551,0.00535681968205712,-0.074603415450787,-0.0536046822971231,7.84843283427161e-33
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23536.Triglycerides in Large LDL,42357,0.0720743662902897,0.00573047174151697,0.0608426416769165,0.083306090903663,4.532443500891e-36
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42357,0.0269474826085521,0.00531310780215452,0.0165337913163292,0.0373611739007749,3.99249072735308e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23538.Total Lipids in Medium LDL,42357,0.0103948870240293,0.00534733528223438,-8.58901291500846e-05,0.0208756641772087,0.0519242357875897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23539.Phospholipids in Medium LDL,42357,0.00772378860281498,0.00533750259984105,-0.00273771649287347,0.0181852936985034,0.147898576670488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23540.Cholesterol in Medium LDL,42357,0.00481588135710728,0.00533699029679419,-0.00564461962460932,0.0152763823388239,0.36688269176577
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42357,0.0190528472809802,0.00536155545459724,0.0085441985899696,0.0295614959719908,0.00038132061702542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42357,-0.0331539417703181,0.00531598034072706,-0.0435732632381432,-0.0227346203024931,4.60699839245664e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23543.Triglycerides in Medium LDL,42357,0.0907121631488864,0.0057323517319811,0.0794767537542034,0.101947572543569,6.8896607803735e-56
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23544.Concentration of Small LDL Particles,42357,0.040044043010628,0.00527576059623799,0.0297035522420015,0.0503845337792544,3.4088804504968e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23545.Total Lipids in Small LDL,42357,0.0185985840016193,0.00529220712589147,0.00822585803487197,0.0289713099683665,0.000442338567547048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23546.Phospholipids in Small LDL,42357,0.0119820815657144,0.00525343779074337,0.00168534349585745,0.0222788196355714,0.0225757329237602
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23547.Cholesterol in Small LDL,42357,0.00992264098555079,0.00529374027281926,-0.000453089949174956,0.0202983719202765,0.0608960325408835
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42357,0.0236034957081336,0.00532173725853077,0.0131728906814133,0.0340341007348539,9.26901345384301e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42357,-0.0253473372255569,0.00527825249174349,-0.0356927121093742,-0.0150019623417397,1.58642720037336e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23550.Triglycerides in Small LDL,42357,0.118920373694477,0.00572390687114066,0.107701516227041,0.130139231161912,2.31065578302235e-94
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42357,-0.128277256550108,0.00595313188934923,-0.139945395053232,-0.116609118046983,3.08252274323576e-101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42357,-0.129875690263144,0.00598246900977954,-0.141601329522312,-0.118150051003976,1.0487684625019e-102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42357,-0.126959249657586,0.00602908137959996,-0.138776249161602,-0.11514225015357,7.60689753340966e-97
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42357,-0.14013924609775,0.00589818653074776,-0.151699691698016,-0.128578800497485,3.20196352436032e-122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42357,-0.155131793527636,0.00593191600693753,-0.166758348901233,-0.143505238154038,5.13936478266988e-147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42357,-0.0839569472242714,0.00572107220717748,-0.0951702487503392,-0.0727436456982035,2.24487835961978e-48
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42357,0.0449632369926272,0.00566278686849737,0.0338641747303724,0.0560622992548821,2.18279803495763e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23558.Concentration of Large HDL Particles,42357,-0.209757795276313,0.00605582959515831,-0.221627221282823,-0.197888369269802,1.13986560945068e-251
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23559.Total Lipids in Large HDL,42357,-0.207891974776949,0.00607171466872586,-0.219792535527652,-0.195991414026246,3.3184052749254e-246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23560.Phospholipids in Large HDL,42357,-0.204314217551331,0.00607577639980976,-0.216222739294958,-0.192405695807704,6.58016949107756e-238
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23561.Cholesterol in Large HDL,42357,-0.211393677121062,0.00599216062476693,-0.223138311945605,-0.199649042296519,1.39370387344783e-260
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42357,-0.21585186225885,0.00596732751226007,-0.22754782418288,-0.20415590033482,3.09777492103966e-273
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42357,-0.192403047288687,0.00605559642386202,-0.204272016279456,-0.180534078297917,1.59582983263499e-213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23564.Triglycerides in Large HDL,42357,-0.0159835971837618,0.00585566193740429,-0.0274606945810742,-0.00450649978644937,0.00634960781474526
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42357,-0.192599143190101,0.00567495443535107,-0.203722053883389,-0.181476232496813,4.15663338099627e-242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23566.Total Lipids in Medium HDL,42357,-0.177563480840299,0.00566151249374364,-0.188660045328037,-0.166466916352562,2.67508248882689e-208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23567.Phospholipids in Medium HDL,42357,-0.158109453336568,0.00567434162223908,-0.169231162916157,-0.146987743756979,4.57939528734023e-166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23568.Cholesterol in Medium HDL,42357,-0.208848293359597,0.00561502888349976,-0.219853749971257,-0.197842836747938,5.07197035583926e-288
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42357,-0.209969743464456,0.00558025342624606,-0.220907040179898,-0.199032446749014,2.21422604655404e-294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42357,-0.197148699826695,0.00575302140944156,-0.208424621789201,-0.18587277786419,1.31918865554759e-246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23571.Triglycerides in Medium HDL,42357,0.0662308974247055,0.00564980202622774,0.0551572854532991,0.0773045093961119,1.39971328154009e-31
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23572.Concentration of Small HDL Particles,42357,-0.0831155426581508,0.005389395435947,-0.0936787577126069,-0.0725523276036947,3.39374617324124e-53
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23573.Total Lipids in Small HDL,42357,-0.0667943381833796,0.00544739025725793,-0.0774712230876052,-0.0561174532791541,2.23896996731297e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23574.Phospholipids in Small HDL,42357,-0.0696049548636919,0.00547783204526501,-0.0803415056724113,-0.0588684040549725,8.92806382739478e-37
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23575.Cholesterol in Small HDL,42357,-0.100018779327181,0.00536268479908942,-0.110529641533397,-0.0895079171209661,1.20417656148217e-76
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42357,-0.098454893330829,0.00533598607848944,-0.108913426044668,-0.0879963606169897,4.50425153496433e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42357,-0.0917706442384433,0.0055105319957058,-0.102571286950027,-0.0809700015268599,1.21441936493573e-61
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23578.Triglycerides in Small HDL,42357,0.132854455019203,0.00566375765874531,0.121753490008063,0.143955420030344,3.08278105462213e-119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,0.0236091013913473,0.00553314285867205,0.0127641413883501,0.0344540613943445,1.99689475854835e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,-0.0606381988033238,0.00568054939715478,-0.0717720756217472,-0.0495043219849005,1.73180555622044e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,-0.0359857085695631,0.00564276528785961,-0.0470455285337679,-0.0249258886053583,1.86471371276707e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,-0.0882069030761322,0.00567698002853507,-0.099333783932061,-0.0770800222202035,6.05683073023481e-54
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41876,0.0371958025607443,0.0056553890046555,0.0261112401116195,0.0482803650098691,4.98688089022457e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42237,0.0680935558246476,0.0055008298145125,0.0573119293882031,0.0788751822610921,5.35263200515959e-35
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42237,-0.105895487451911,0.00572254583861424,-0.117111677295595,-0.0946792976082276,1.73724594828134e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42237,-0.112273075488788,0.00571934532850139,-0.123482992332651,-0.101063158644926,1.40670114048256e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42237,-0.0615235610531648,0.00570343092016799,-0.0727022856566941,-0.0503448364496356,5.14866493103468e-27
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42237,0.0742489686871539,0.00564908674977975,0.0631767586575856,0.0853211787167222,3.28943265624727e-39
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42356,0.140236179827682,0.00551800371854494,0.129420892539334,0.15105146711603,3.8616638263463e-139
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42356,-0.0362987771446594,0.00547733334808164,-0.0470343505068994,-0.0255632037824194,3.55703687790285e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42356,-0.0691253093330847,0.00561393606938474,-0.0801286240290788,-0.0581219946370906,1.19357100743741e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42356,0.0498357284667703,0.00540029685992709,0.0392511466213132,0.0604203103122274,3.16305762646301e-20
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42356,-0.0343655116118989,0.00538773865251796,-0.0449254793708341,-0.0238055438529637,1.84852911571258e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42357,-0.0655495346831398,0.00546233969385908,-0.0762557204831036,-0.054843348883176,5.26455081540366e-33
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42357,-0.109918359256782,0.00562381520382289,-0.120941037056275,-0.0988956814572893,6.97890286953538e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42357,-0.11757805397395,0.00567001588675815,-0.128691285111996,-0.106464822835904,5.09713618826496e-94
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42357,-0.0863205279284344,0.0055137921660724,-0.0971275605739363,-0.0755134952829325,9.50811337224051e-55
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42357,0.101150243696281,0.00558467122475125,0.0902042880957688,0.112096199296794,1.93309477615007e-72
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42357,-0.108481017134952,0.00560341336453591,-0.119463707329443,-0.0974983269404619,2.3435608629893e-82
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42357,-0.0587649923481676,0.00551042382890705,-0.0695654230528254,-0.0479645616435098,1.91639097255278e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42357,-0.0150296132351172,0.00542356427780342,-0.0256597992196119,-0.00439942725062253,0.00559338179269003
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42357,-0.112915436074477,0.00561926267290924,-0.123929190913379,-0.101901681235575,1.74557298136527e-88
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42357,0.0747691555124698,0.00554624571680904,0.0638985139075241,0.0856397971174155,3.79128295041906e-41
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42357,0.151498854970278,0.00540433087294548,0.140906366459305,0.162091343481251,5.28124273904339e-168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42357,-0.123340320091678,0.00565660755129599,-0.134427270892218,-0.112253369291138,1.41234343818419e-103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42357,-0.133600524222607,0.00568876643811461,-0.144750506441311,-0.122450542003902,1.63769876354355e-119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42357,-0.0243724300078299,0.00544030245186719,-0.0350354228134896,-0.0137094372021702,7.52801066475939e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42357,0.102135432065634,0.0056632845200018,0.0910353944064301,0.113235469724837,7.60878514610477e-72
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42357,0.0833926816349752,0.00518926939533002,0.0732217136201284,0.093563649649822,1.45483602127114e-57
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42357,-0.127890741997577,0.00544242685372384,-0.138557898630875,-0.117223585364278,1.19717611184089e-119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42357,-0.124271057706454,0.00543904448667291,-0.134931584900333,-0.113610530512575,2.41879413083553e-113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42357,-0.0556154373540381,0.00531441445965347,-0.0660316896949589,-0.0451991850131172,1.57497842239406e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42357,0.128604459052593,0.00561856524564701,0.117592071171125,0.139616846934061,9.74767732375241e-114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42357,0.021141170017015,0.00530919220176084,0.0107351533015638,0.0315471867324663,6.87069235639836e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42357,-0.134854949218135,0.00564069881260454,-0.14591071889084,-0.12379917954543,1.08782868609911e-123
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42357,-0.0296419196556289,0.00537028271142166,-0.0401676737700154,-0.0191161655412425,3.46161114446547e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42357,-0.147780464244614,0.00561131968703518,-0.158778650831203,-0.136782277658025,5.17942903808997e-149
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42357,0.117369355185424,0.00565477771526629,0.106285990863502,0.128452719507346,3.47858691722609e-94
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42357,-0.0246122588916525,0.00544195568757153,-0.0352784920392927,-0.0139460257440123,6.15932762977411e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42357,-0.0664063956981093,0.00527548017116128,-0.0767463368335854,-0.0560664545626332,3.98165190998945e-36
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42357,0.0721819449804894,0.00545375823216608,0.0614925788454439,0.0828713111155349,9.84754932231833e-40
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42357,-0.155561806275056,0.0057171994348029,-0.166767517167269,-0.144356095382842,1.17813738954115e-158
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42357,0.0905837877370186,0.00558815295006385,0.0796310079548935,0.101536567519144,1.57964631870496e-58
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42357,-0.0320642266948473,0.00537215693210616,-0.0425936542817753,-0.0215347991079192,2.45461072733386e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42357,-0.0630508595470363,0.00539057452521345,-0.0736163856164547,-0.052485333477618,1.90026429775807e-31
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42357,0.0368419341252515,0.00537603167670523,0.0263049120389092,0.0473789562115937,7.55375258442081e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42357,-0.120628355448821,0.00566140677087876,-0.131724712719744,-0.109531998177899,4.55253114818554e-99
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42357,0.120169541744353,0.00565854461514025,0.109078794298678,0.131260289190028,1.93890407156103e-98
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42348,-0.09487309420644,0.00593133014306842,-0.106498501286854,-0.0832476871260259,4.75506447212679e-57
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42348,0.00818406031996317,0.00566156044624716,-0.00291259815468126,0.0192807187946076,0.148327697996785
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42348,-0.113842092966493,0.00540794469708919,-0.124441664572788,-0.103242521360198,8.78113789116109e-97
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42348,0.175721381115421,0.00607418700972448,0.163815974576361,0.187626787654481,1.86327183581596e-178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42348,0.142584458856829,0.00583625159819993,0.131145405724358,0.154023511989301,5.88434075686881e-129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42357,0.106183898910868,0.00574617796998029,0.0949213900897067,0.117446407732029,2.72044224672847e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42357,-0.159888865172699,0.00585000139993307,-0.171354867916567,-0.14842286242883,5.03435464283163e-160
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42357,-0.166487816535995,0.00587526611448122,-0.178003338120379,-0.154972294951612,1.60913998285254e-171
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42357,-0.0570680407774905,0.00569809069319279,-0.0682362985361484,-0.0458997830188326,1.58516621809198e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42357,0.164365826549476,0.00576575102093889,0.153064954548436,0.175666698550516,1.67770830566429e-173
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42357,0.214451529811047,0.00561267799492876,0.203450680940987,0.225452378681107,5.14929839277691e-303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42357,-0.200625369835785,0.00559847862375107,-0.211598387938337,-0.189652351733233,1.9315871216171e-268
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42357,-0.177382492015322,0.00561919532679613,-0.188396114855842,-0.166368869174802,6.79619639371852e-211
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42357,-0.198716250817772,0.00588628419014061,-0.210253367830447,-0.187179133805096,1.10879021879939e-239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42357,0.175106821757053,0.00557996028098317,0.164170099606326,0.18604354390778,1.57563093520189e-208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42357,-0.0251483627583808,0.00565777388052394,-0.0362375995642077,-0.0140591259525539,8.86427000384528e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42357,-0.10616519075338,0.00558509064649803,-0.117111968420516,-0.0952184130862438,1.67294331021511e-79
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42357,-0.0875627879378591,0.00566365558917985,-0.0986635528926516,-0.0764620229830666,1.89048127720813e-53
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42357,-0.0691324762340756,0.00561803268390496,-0.0801438202945294,-0.0581211321736219,1.31162406075916e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42357,0.190816169034642,0.00560072078086396,0.179838756304148,0.201793581765135,6.79631810549208e-244
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51637,0.00264831449668467,0.0047763395118675,-0.00671331094657564,0.012009939939945,0.579265975505066
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51637,0.00115885275268232,0.0046503109856046,-0.0079557567791027,0.0102734622844673,0.803209149120306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50195,0.00545868999581093,0.00445336265625698,-0.00326990081045276,0.0141872808020746,0.220308142917898
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50195,0.0049924491608893,0.00489367462257583,-0.00459915309935933,0.0145840514211379,0.307652897169682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50195,0.00174611275376034,0.00477965160912806,-0.00762200440013065,0.0111142299076513,0.714874601434732
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50195,0.00358692254725833,0.00435086433745059,-0.00494077155414482,0.0121146166486615,0.409712540964942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24009.Traffic intensity on the nearest road,51637,-0.0681864813136372,0.0452526092810446,-0.156881595504485,0.0205086328772102,0.131876856721166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24010.Inverse distance to the nearest road,51637,0.0013542453358099,0.0041733954664738,-0.00682560977847874,0.00953410045009854,0.745566444886503
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24011.Traffic intensity on the nearest major road,51637,0.013922323119551,0.00412141611981229,0.00584434752471894,0.0220002987143831,0.000731275697886314
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24012.Inverse distance to the nearest major road,51637,-0.00615766675427872,0.00419505784618586,-0.014379980132803,0.00206464662424556,0.142162153524916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24013.Total traffic load on major roads,51637,-0.0461062673272782,0.0313787866471507,-0.107608689155694,0.0153961545011372,0.14175321942185
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24015.Sum of road length of major roads within 100m,51637,-0.0404336281537142,0.0303843094286866,-0.09998687463394,0.0191196183265115,0.183287964267592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51637,-0.00511420780344442,0.00474716060972333,-0.0144186425985021,0.00419022699161331,0.281349216959232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51637,-0.00472704142174842,0.00473677327505505,-0.0140111170408563,0.00455703419735947,0.318316561818777
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51637,-0.0074456919963492,0.00468291437807733,-0.0166242041773808,0.00173282018468236,0.111855719027909
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51583,-0.00116692100078238,0.00465953394508031,-0.0102996075331398,0.00796576553157502,0.80225150168937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24020.Average daytime sound level of noise pollution,51637,0.000260531617393616,0.00419422871186786,-0.00796015665786739,0.00848121989265463,0.950470456698972
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24021.Average evening sound level of noise pollution,51637,0.000328864663625464,0.00419500912770687,-0.00789335322667999,0.00855108255393092,0.937515133036045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24022.Average night-time sound level of noise pollution,51637,0.000245100411094047,0.00419423365747564,-0.0079755975575582,0.0084657983797463,0.953400687842897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51637,0.000252796653322884,0.00419467918055398,-0.00796877454056292,0.00847436784720869,0.951944295008988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51637,0.000282551683560157,0.00419451641539741,-0.00793870049061876,0.00850380385773907,0.946293993183096
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2405.Number of children fathered,39908,0.0712039236017306,0.0357105230806547,0.0012112983636475,0.141196548839814,0.0461861101063696
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49378,-0.00382646271787089,0.00482693250934436,-0.0132872504361858,0.00563432500044406,0.42794343787073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49378,0.00902624886333687,0.004332353572785,0.000534835860678276,0.0175176618659955,0.0372226328592824
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24502.Water percentage, buffer 1000m",49378,-0.00878009924872661,0.00440430672448722,-0.0174125404287216,-0.000147658068731666,0.0462173325847426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49378,0.00224457807259915,0.00452532883926264,-0.00662506645235564,0.0111142225975539,0.619897478046076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49378,0.00262869785555678,0.00435829484196656,-0.00591356003469768,0.0111709557458112,0.546416855599124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24505.Water percentage, buffer 300m",49378,-0.00814780710777375,0.00443648798410024,-0.0168433235566102,0.000547709341062717,0.0662918807015557
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51782,-0.00642664294278301,0.00467255708960909,-0.0155848548384168,0.0027315689528508,0.169020583248425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51782,0.000736534229277706,0.00437203401010729,-0.00783265243053257,0.00930572088908799,0.866219070821935
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24508.Distance (Euclidean) to coast,51782,0.00890222882466125,0.00412129798273211,0.000824484778506317,0.0169799728708162,0.0307789252091057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35416,0.0244936290098013,0.0408162917050162,-0.0555063027320305,0.104493560751633,0.548465163527086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2704.Years since last cervical smear test,38265,0.0284416132042278,0.0350567342585708,-0.040269585942571,0.0971528123510267,0.417213309620698
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2714.Age when periods started (menarche),40669,0.0343982290344556,0.0280856396274796,-0.0206496246354044,0.0894460827043155,0.220689982142015
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2734.Number of live births,41015,0.0580110299573203,0.0275468188781531,0.00401926495614018,0.1120027949585,0.0352335028455529
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2744.Birth weight of first child,39220,-0.0940740647085374,0.0293999127394849,-0.151697893677928,-0.036450235739147,0.00137947908017713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2754.Age at first live birth,38011,-0.0289637778356752,0.00755921353262021,-0.0437798363596108,-0.0141477193117396,0.000128203567208296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2764.Age at last live birth,37981,-0.0106463727539685,0.00692513781395267,-0.0242196428693158,0.0029268973613787,0.124243196248077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2794.Age started oral contraceptive pill,36921,0.0131215755572715,0.0108442319791106,-0.00813311912178537,0.0343762702363283,0.226313961468395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2804.Age when last used oral contraceptive pill,36151,0.00739015481108482,0.00811725610991237,-0.00851966716434342,0.0232999767865131,0.362629830855861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2867.Age started smoking in former smokers,36123,-0.00890946741403291,0.00789893700321927,-0.0243913839403427,0.00657244911227686,0.259387494135754
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35953,-0.0193651266573886,0.0481863602746561,-0.113810392795714,0.0750801394809373,0.687785172215268
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35950,-0.0215970156725119,0.0523778244324404,-0.124257551560095,0.0810635202150713,0.680109707376063
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35965,0.00733752723753327,0.0546907152124228,-0.0998562745788154,0.114531329053882,0.89327685027648
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35941,0.0272583670324993,0.053299047972285,-0.0772077669931793,0.131724501058178,0.609071528637601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28739.Difficulty with standing for long periods,35971,0.119834235568206,0.040603692899606,0.0402509974849782,0.199417473651434,0.00317509931379101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28740.Difficulty with taking care of household responsibilities,35993,0.070634799477253,0.0453025089257892,-0.018158118017294,0.1594277169718,0.119000170954866
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28741.Difficulty learning a new task,35934,0.0765996468639793,0.051323757799258,-0.0239949184225664,0.177194212150525,0.135620361278661
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28742.Difficulty with joining in community activities,35668,-0.0084341834390907,0.0562284009538983,-0.118641849308731,0.10177348243055,0.880770366337678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28743.Difficulty with being emotionally affected by health problems,35952,0.10528434601003,0.0464322885983727,0.0142770603572193,0.19629163166284,0.0233922957995823
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35995,0.0923856270969852,0.0712235327575686,-0.0472124971078493,0.23198375130182,0.194633156575474
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,35654,0.0688138631473404,0.039841202064637,-0.00927489289934813,0.146902619194029,0.0841789245185176
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2897.Age stopped smoking,36127,0.0457084170402807,0.00744261792645291,0.031120885904433,0.0602959481761284,8.62939019223461e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35260,-0.0254763547082476,0.0173254755192525,-0.0594342867259826,0.00848157730948733,0.141490077881513
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35260,0.0380384579477079,0.0194760554334839,-0.000134610701920432,0.0762115265973363,0.0508550370313991
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35260,0.0849877004661282,0.0629455105375149,-0.038385500187401,0.208360901119657,0.177008976818869
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35260,-0.114506332601747,0.0747515446765374,-0.261019360167761,0.0320066949642661,0.125617614706272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35260,-0.031331171979784,0.090984206429328,-0.209660216581267,0.146997872621699,0.730588738057819
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35260,0.0210792399953415,0.0765219741164284,-0.128903829272858,0.171062309263541,0.782967246208775
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35260,0.0123139252622982,0.0315849570944468,-0.0495925906428176,0.074220441167414,0.696648753398357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35260,0.10881773059806,0.0536081302539062,0.00374579530040423,0.213889665895717,0.0424129419561136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29002.Recent lack of interest or pleasure in doing things,35213,0.0670473059083783,0.0558289401094069,-0.0423774167060593,0.176472028522816,0.22982106442345
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29003.Recent feelings of depression,35201,0.0313978405975215,0.0544827172039768,-0.0753882851222729,0.138183966317316,0.564440835038544
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35214,0.0412367964487613,0.0423319171748973,-0.0417337612140375,0.12420735411156,0.330031078615558
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29005.Recent feelings of tiredness or low energy,35217,0.0644883002190099,0.0420825698251442,-0.0179935366382727,0.146970137076292,0.125470609683243
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29006.Recent poor appetite or overeating,35229,0.0214971187877738,0.0654893970820551,-0.106862099493054,0.149856337068602,0.742731449243665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29007.Recent feelings of inadequacy,35195,0.0589030577128181,0.0608822198722178,-0.0604260932367287,0.178232208662365,0.333337164824169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29008.Recent trouble concentrating on things,35227,0.0622448090302947,0.0586010110675416,-0.0526131726620867,0.177102790722676,0.288196607605666
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35221,0.188632864384327,0.0959029505713128,0.000663081264554222,0.3766026475041,0.0492389374701656
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29010.Recent thoughts of suicide or self-harm,35201,0.158541815830216,0.110186318866738,-0.0574233691485904,0.374507000809023,0.150244550569311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#0.Substances taken for depression_None of options listed,36249,-0.00475248318228123,0.0348096686189241,-0.0729794336753725,0.06347446731081,0.891408042124886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36249,-0.221757136203986,0.089488250997945,-0.397154108159958,-0.0463601642480141,0.0132331658023601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36249,0.0245380491725502,0.0357598996648762,-0.0455513541706072,0.0946274525157076,0.492616494008251
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36249,0.00155969623715725,0.107722116650833,-0.209575652398475,0.21269504487279,0.988448333508469
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36249,-0.0989727808857657,0.0913592914309757,-0.278036992090478,0.0800914303189467,0.278696472355197
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36249,0.126047858347239,0.0933496965268806,-0.0569175468454472,0.309013263539925,0.176970769442694
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36249,0.0945271323046514,0.101751551858151,-0.104905909337324,0.293960173946626,0.352921172047933
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36249,0.0782042147168375,0.0967393267656364,-0.11140486574381,0.267813295177485,0.4188867596664
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36249,0.0915530099435753,0.0628819774117465,-0.0316956657834479,0.214801685670598,0.145450961839252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36249,-0.00524942379171153,0.0320135232655415,-0.0679959293921729,0.0574970818087499,0.869755366427671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36249,-0.0533494463907867,0.0564659096023029,-0.1640226292113,0.057323736429727,0.344789232624608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36249,-0.0702878217173227,0.0860026600193642,-0.238853035355277,0.0982773919206311,0.413798903198185
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36249,-0.123706275554399,0.12358458914773,-0.36593207028395,0.118519519175152,0.316868564349344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36249,-0.0938212550387954,0.0843540592464413,-0.25915521116182,0.0715127010842295,0.266076458141504
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36249,0.0358509752675259,0.116866067362402,-0.193206516762782,0.264908467297834,0.759027681675009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36249,-0.145233835848166,0.116933294123773,-0.374423092330761,0.08395542063443,0.214269377579241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36249,-0.100813588501653,0.0686620675581407,-0.235391240915609,0.0337640639123026,0.142078900673615
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36249,-0.100069353045098,0.0637977453680203,-0.225112933966418,0.0249742278762217,0.116799872406633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36249,-0.0758391916094287,0.0893686949388983,-0.251001833689669,0.0993234504708119,0.396126986515321
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29058.Recent feelings or nervousness or anxiety,35125,-0.00620534727983201,0.050217030891775,-0.104630727827711,0.092220033268047,0.901659481855223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29059.Recent inability to stop or control worrying,35137,0.0622594967046276,0.0508766827933014,-0.037458801570243,0.161977794979498,0.221101340876977
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29060.Recent worrying too much about different things,35135,-0.00566742526622916,0.0476763766097478,-0.0991131234213349,0.0877782728888765,0.905380137055085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29061.Recent trouble relaxing,35131,0.06150350894336,0.0511115509880491,-0.0386751309932161,0.161682148879936,0.228900830654326
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29062.Recent restlessness,35147,-0.0220713524737445,0.0760627137345476,-0.171154271393458,0.127011566445969,0.771693934368342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29063.Recent easy annoyance or irritability,35119,0.0645079129227251,0.0519207730079878,-0.0372568021729309,0.166272628018381,0.214127232443633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29064.Recent feelings of foreboding,35119,0.129846213009341,0.0579445403483969,0.0162749139264828,0.243417512092199,0.0250713724558978
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36249,-0.0982235115311509,0.0395632242685449,-0.175767431097499,-0.0206795919648028,0.0130622574662806
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36249,-0.0174082916384217,0.0708212861559428,-0.15621801250407,0.121401429227226,0.805839621847694
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36249,-0.0853793410491134,0.0868669962595261,-0.255638653717785,0.0848799716195578,0.325702995775147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36249,-0.0107392999761845,0.0806952916107729,-0.168902071533299,0.14742347158093,0.894130276005743
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#2.Symptoms of panic attack_Sweating,36249,0.029602307101637,0.0620539852542275,-0.0920235039966488,0.151228118199923,0.633347565658012
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36249,0.0581450304479972,0.0639051430148157,-0.0671090498610416,0.183399110757036,0.362924978486764
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36249,-0.0235325252800945,0.0659599519074644,-0.152814031018725,0.105748980458536,0.72127474333136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36249,0.0248039663300793,0.0659710823899158,-0.104499355154156,0.154107287814314,0.706941280422855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36249,0.0761046489871503,0.0844757615628556,-0.0894678436760468,0.241677141650347,0.367669502665346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29076.Felt loved as a child,35117,-0.0425161494102283,0.0431507164880508,-0.127091553726808,0.0420592549063514,0.324519861661868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29077.Physically abused by family as a child,35136,-0.0336775144918377,0.0655491946361358,-0.162153935978664,0.0947989069949885,0.607428667419196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29078.Felt hated by family member as a child,35124,0.0933864988055949,0.0637657988730831,-0.0315944669856479,0.218367464596838,0.143104055941368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29079.Sexually molested as a child,35078,0.172269021477944,0.0805205344414874,0.0144487739726289,0.330089268983259,0.0324409272002032
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29080.Someone to take to doctor when needed as a child,35095,-0.112913962503896,0.0589743397712475,-0.228503668455541,0.00267574344774944,0.0555882013156079
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35129,0.0515003221688687,0.095021118354755,-0.134741069806451,0.237741714144189,0.587847005059515
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35084,0.0429905174866994,0.0712027373484663,-0.0965668477162945,0.182547882689693,0.546015707088157
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35133,-0.100341615344788,0.0852765547338838,-0.267483662623201,0.0668004319336239,0.23937791602575
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35122,-0.0579510116603696,0.116712275417732,-0.286707071479125,0.170805048158386,0.619539753336378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35121,-0.0958268476249619,0.108485311596942,-0.308458058354968,0.116804363105044,0.377101213427815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29086.Experienced a violent or sexual assault,35135,-0.10441142255818,0.103942978852754,-0.308139661109577,0.0993168159932182,0.31517534268564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29087.Experienced a life-threatening injury or illness,35129,0.112091275496229,0.0480211169930775,0.0179698861897967,0.206212664802661,0.0196180315448853
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29088.Experienced a marital separation or divorce,35135,-0.0651022527140828,0.0498602015198834,-0.162828247693054,0.0326237422648887,0.191706613068874
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29089.Experienced the death of a spouse or partner,35142,0.020948395766532,0.0529774016984357,-0.082887311562402,0.124784103095466,0.692546137364448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35134,-0.0360302625380727,0.0632649041555745,-0.160029474682999,0.0879689496068533,0.569028762592126
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29091.Frequency of drinking alcohol,35134,-0.340379476488548,0.0400095288571227,-0.418798153048509,-0.261960799928588,2.22605347345379e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,34405,-0.278691168962735,0.0510362587610424,-0.378722236134378,-0.178660101791092,4.96395766467372e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,34425,-0.254430182547513,0.0529648640004008,-0.358241315988298,-0.150619049106727,1.60068709739187e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29104.Ever used cannabis,35134,-0.183436460385383,0.0755060343549093,-0.331428287721005,-0.0354446330497608,0.0151521417756767
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29108.Ever thought that life not worth living,35101,0.0736523964697508,0.0534221311985032,-0.0310549806793155,0.178359773618817,0.168043502607787
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29109.Ever contemplated self-harm,35127,0.170656472080915,0.0780126140268201,0.0177517485883479,0.323561195573483,0.0287413142924062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29111.Ever self-harmed,35134,0.163404694853927,0.1385138961924,-0.108082541683177,0.434891931391031,0.238167232553516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35123,-0.0361678708197887,0.081972473111959,-0.196833918119228,0.124498176479651,0.659070036778623
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36861,-0.0560980879100258,0.0944758917742747,-0.241270835787604,0.129074659967553,0.552675419321117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36861,-0.132280825790857,0.0693875844295777,-0.268280491272829,0.00371883969111558,0.0566350523391596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36861,-0.0200338608596828,0.0831183330388835,-0.182945793615894,0.142878071896529,0.809539717792833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36861,-0.012199974547027,0.122811104673991,-0.252909739708049,0.228509790613995,0.920871438185797
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35114,-0.103330761068903,0.0463026207837918,-0.194083897805135,-0.0125776243326712,0.0256760859648174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X29153.Pain or discomfort today,35125,0.0822410551413711,0.0412660576320171,0.00135958218261754,0.163122528100125,0.0463130453270241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29154.Anxiety or depression today,35125,0.103181313100047,0.0532622024128191,-0.00121260362907891,0.207575229829172,0.0527642761996964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29166.Frequency of confiding in someone close,34948,-0.0110306520358143,0.0411964253048721,-0.0917756456333636,0.0697143415617349,0.788895586962799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35108,-0.00984034486357716,0.0168582492257898,-0.0428825133461251,0.0232018236189708,0.559437051776938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35108,-0.0188345322892287,0.0172572917604195,-0.0526588241396509,0.0149897595611935,0.27514330880018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35108,-0.00991398937483057,0.0215472375340542,-0.0521465749415768,0.0323185961919156,0.645457848554762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35108,0.0322040352079892,0.0199211130015382,-0.00684134627502558,0.071249416691004,0.106022715783442
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35108,0.0281147593800299,0.0343001193974058,-0.0391134746388854,0.0953429933989453,0.412437612129439
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35108,0.00694288530459925,0.0162992505970752,-0.0250036458656682,0.0388894164748667,0.67014996786581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35105,-0.0373705308945837,0.0175117757958199,-0.0716936114543908,-0.00304745033477664,0.0328819431468216
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35105,0.0233380908837557,0.0270446583928426,-0.0296694395662158,0.0763456213337272,0.388201942251021
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35105,0.00774135581117911,0.0389497558036954,-0.0686001655640638,0.0840828771864221,0.842463300652651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35105,0.123403390238629,0.0311877529103708,0.0622753945343026,0.184531385942956,7.68533011488358e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35105,0.0822637287269857,0.0519639789775196,-0.0195856700689527,0.184113127522924,0.113454129447643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35105,0.0356344259563421,0.0237738900988852,-0.0109623986374729,0.0822312505501571,0.133955792790222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29171.Frequency of feeling 'in tune' with people,35006,-0.0642457703839728,0.0524051736845676,-0.166959910805725,0.0384683700377797,0.220269700058024
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29172.Freuency of feeling that lacks companionship,35087,0.047228917122515,0.0475270356750384,-0.0459240728005602,0.14038190704559,0.320396411741529
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29173.Frequency of feeling left out,35044,0.18577893221339,0.0498646849161454,0.0880441497777447,0.283513714649035,0.000196639735012613
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29174.Frequency of feeling isolated from others,35077,0.0837011774361417,0.0520162722575054,-0.0182507161885689,0.185653071060852,0.107640602818269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29175.Tendency to bounce back quickly after hard times,35120,-0.0670475271345421,0.0413760921571649,-0.148144667762585,0.0140496134935011,0.105190754346087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29176.Ability to make it through stressful events,35120,0.0104471178711906,0.039751874951147,-0.0674665570330576,0.0883607927754388,0.792707571689343
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29177.Quick recovery from stressful events,35120,-0.0364307335883359,0.0411209543742529,-0.117027804161872,0.0441663369851999,0.375685364517622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29178.Hard to snap back when something bad happens,35120,0.0274634526511107,0.040237204589838,-0.0514014683449717,0.106328373647193,0.494925020247235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29179.Comes through difficult times with little trouble,35120,0.0132616564392555,0.0409996304942861,-0.0670976193295453,0.0936209322080563,0.746359867540031
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29180.Tendency to take a long time to get over setbacks,35120,0.0248948299050374,0.040468566332067,-0.0544235601058139,0.104213219915889,0.538469648967705
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29181.General happiness,35093,0.0809674713018785,0.0421814781352717,-0.001708225843254,0.163643168447011,0.0549689306803722
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29182.Belief that own life is meaningful,35001,-0.0270797362052721,0.0419034293053449,-0.109210457643748,0.0550509852332038,0.518148499721296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,35473,0.0193203132674585,0.0375385928467145,-0.0542553287121018,0.0928959552470188,0.6067956922026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2946.Father's age,30166,-0.00609355272081798,0.0389885399924038,-0.0825110911059295,0.0703239856642935,0.875836208833729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2966.Age high blood pressure diagnosed,36675,-0.00491612091594359,0.00775081144602051,-0.0201077113501438,0.0102754695182566,0.525922868727969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30000.White blood cell (leukocyte) count,51190,0.186847791416659,0.00431891749875038,0.178382713119109,0.19531286971421,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51191,0.0078876709601425,0.00474104768817676,-0.00140478250868394,0.0171801244289689,0.0961870658570095
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30020.Haemoglobin concentration,51191,-0.0386219088380812,0.00508294564837642,-0.0485844823088989,-0.0286593353672634,3.11938640572573e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30030.Haematocrit percentage,51191,-0.0232151177274689,0.0049524515265601,-0.0329219227195267,-0.0135083127354111,2.7808256075325e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30040.Mean corpuscular volume,51191,-0.0451710411157091,0.00433016902362643,-0.0536581724020169,-0.0366839098294013,2.03679141928632e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51191,-0.0569839892084247,0.00434390651677636,-0.0654980459813064,-0.0484699324355431,3.63700394523264e-39
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51191,-0.0328855522950948,0.00426185414449155,-0.0412387864182982,-0.0245323181718913,1.24881392010638e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51191,0.0183197515115208,0.00439840768849504,0.00969887244207051,0.0269406305809711,3.12420112663654e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30080.Platelet count,51191,0.165324358427149,0.00416608310958013,0.157158835532372,0.173489881321926,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30090.Platelet crit,51191,0.164438959906016,0.00424808995974494,0.156112703584916,0.172765216227116,1.66880539479192e-308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51191,-0.0480270127901943,0.00409940599970748,-0.056061848549621,-0.0399921770307677,1.31641735569943e-31
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30110.Platelet distribution width,51191,-0.0222346906404871,0.00426682747568437,-0.0305976724928285,-0.0138717087881458,1.8945959648138e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30120.Lymphocyte count,51152,0.186218587518586,0.00404280034942191,0.178294698833719,0.194142476203453,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30130.Monocyte count,51152,0.107181123032694,0.00427988520528521,0.0987925480303348,0.115569698035053,1.71016642692652e-136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30140.Neutrophill count,51152,0.116084343026415,0.00438855407643881,0.107482777036595,0.124685909016235,8.33377798040601e-152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30150.Eosinophill count,51152,0.0918617273525258,0.00419806807166572,0.083633513932061,0.100089940772991,5.11788410354091e-105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30160.Basophill count,51152,0.308728593340474,0.0231014078246453,0.263449834004169,0.354007352676778,1.41302920504948e-40
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30170.Nucleated red blood cell count,51152,0.322122334173742,0.0996505211637654,0.126807312692762,0.517437355654722,0.00122884460324939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30180.Lymphocyte percentage,51153,0.0619424212170224,0.0042043685513224,0.0537018588564305,0.0701829835776143,6.78881131011008e-49
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30190.Monocyte percentage,51153,-0.0201218076067326,0.00428743995905837,-0.028525189926487,-0.0117184252869782,2.7058809343769e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30200.Neutrophill percentage,51153,-0.0549376104669585,0.0041790345200645,-0.0631285181262849,-0.0467467028076321,2.52597925138008e-39
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30210.Eosinophill percentage,51153,0.0364065205393859,0.00420548501567182,0.0281637699086691,0.0446492711701027,5.17515428451806e-18
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30220.Basophill percentage,51153,-0.00832047854411213,0.00421070866668801,-0.0165734675308206,-6.74895574036306e-05,0.0481640939600898
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30230.Nucleated red blood cell percentage,51152,0.321164659598737,0.0997183576001386,0.125716678702465,0.516612640495009,0.00128056266209009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30240.Reticulocyte percentage,50815,0.0335682696295573,0.00455357635566517,0.0246432599724536,0.042493279286661,1.74332382200565e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30250.Reticulocyte count,50815,0.0344592762334807,0.00463118925549252,0.0253821452927154,0.0435364071742461,1.03894212230097e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30260.Mean reticulocyte volume,50815,-0.0303856769809589,0.00425139956217444,-0.0387184201228208,-0.022052933839097,9.13697073817911e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30270.Mean sphered cell volume,50815,-0.0404252585184902,0.00430753919718301,-0.0488680353449688,-0.0319824816920115,6.90945372134225e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30280.Immature reticulocyte fraction,50815,0.0300708569342691,0.0044895543398134,0.0212713304282349,0.0388703834403034,2.16540020981838e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50815,0.0383497793421472,0.0046384019535429,0.0292585115132031,0.0474410471710912,1.4413451263394e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30300.High light scatter reticulocyte count,50815,0.0389794066202036,0.00469776476462737,0.0297717876815339,0.0481870255588732,1.12539379306221e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30500.Microalbumin in urine,37005,0.0318110792112256,0.00732968860401909,0.0174448895473482,0.046177268875103,1.44257041795133e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51170,0.0196042531691462,0.00471185079175089,0.0103690256173144,0.0288394807209779,3.18581358801788e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30520.Potassium in urine,51133,-0.010084635493255,0.00442151543725753,-0.0187508057502797,-0.00141846523623019,0.0225692508107886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30530.Sodium in urine,51112,0.00277375159157713,0.00465479760147011,-0.00634965170730428,0.0118971548904585,0.55125425751772
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30600.Albumin,48998,-0.0709802658407419,0.00454465340891314,-0.0798877865222117,-0.0620727451592722,1.15612150115697e-54
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30610.Alkaline phosphatase,50785,0.0641818762675802,0.00446802936145558,0.0554245387191272,0.0729392138160331,1.41336139879902e-46
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30620.Alanine aminotransferase,50789,0.0128016963927953,0.0047901788545839,0.0034129458378109,0.0221904469477798,0.0075347564820478
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30630.Apolipoprotein A,48854,-0.223714025431771,0.00475303638011428,-0.233029976736795,-0.214398074126747,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30640.Apolipoprotein B,50689,0.0262929073786385,0.00417261629226877,0.0181145794457917,0.0344712353114852,3.00889350563426e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30650.Aspartate aminotransferase,50723,-0.0146063180651981,0.00457373906869636,-0.023570846639843,-0.00564178949055323,0.00140752818242963
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30660.Direct bilirubin,47620,-0.0501570408435374,0.00482277114577359,-0.0596096722892536,-0.0407044093978211,2.91109838163213e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30670.Urea,50772,0.0199206072842042,0.0044117855984844,0.0112735075111748,0.0285677070572337,6.3556836917159e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30680.Calcium,48998,-0.00132580505532073,0.00442840017483424,-0.0100054693979958,0.00735385928735438,0.764647988629071
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30690.Cholesterol,50792,-0.0365103205384475,0.00420968976412443,-0.0447613124761314,-0.0282593286007636,4.50377429801088e-18
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30700.Creatinine,50784,0.0281791517123454,0.00489456696433006,0.0185858004622584,0.0377725029624323,8.66641916458254e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30710.C-reactive protein,50730,0.0925411175612778,0.00475581225361816,0.0832197255441863,0.101862509578369,1.28961693056689e-83
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30720.Cystatin C,50798,0.0904195122204111,0.00482037911539599,0.080971569154235,0.0998674552865872,6.95847184188877e-78
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30730.Gamma glutamyltransferase,50786,0.023870596913178,0.00480363343767279,0.0144554753753393,0.0332857184510167,6.77160399976272e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30740.Glucose,48982,-0.00328288908103789,0.0045359294226921,-0.0121733107495144,0.00560753258743863,0.469226410747662
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50741,0.0829991052683194,0.00456903909119815,0.074043788649571,0.0919544218870677,3.40432724171583e-73
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30760.HDL cholesterol,48988,-0.244988498765226,0.00484564894004471,-0.254485970687714,-0.235491026842738,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30770.IGF-1,50666,-0.0151350250311355,0.00439156540991464,-0.0237424932345681,-0.00652755682770276,0.000569227513301485
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30780.LDL direct,50743,0.00446053625827994,0.00413186483054215,-0.00363791880958267,0.0125589913261426,0.280356685809955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30790.Lipoprotein A,46417,-0.00796359783577344,0.00473470044235955,-0.0172436107027982,0.00131641503125127,0.092593861757178
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30810.Phosphate,48960,0.0497678184645133,0.00472751642772772,0.040501886266167,0.0590337506628597,7.57243776759753e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30830.SHBG,48826,-0.059775433347027,0.0054786008351201,-0.0705134909838624,-0.0490373757101916,1.22993906605182e-27
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30840.Total bilirubin,50703,-0.0764335590669958,0.00460326050604985,-0.0854559496588535,-0.0674111684751381,1.56973685477338e-61
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30850.Testosterone,48266,-0.0207313340675842,0.0073343037753247,-0.0351065694672206,-0.00635609866794778,0.00470901649346652
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30860.Total protein,48982,0.0263390216683792,0.00443378228448221,0.0176488083907941,0.0350292349459644,2.88854358233864e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30870.Triglycerides,50779,0.153890591498446,0.00469513737089571,0.144688122251491,0.163093060745402,5.41764452865504e-230
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30880.Urate,50758,0.0493543646538423,0.00516597000349469,0.0392290634469927,0.0594796658606919,1.38026387288594e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30890.Vitamin D,49690,-0.0283985731584972,0.00488350167754061,-0.0379702364464767,-0.0188269098705176,6.14586231541163e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3137.Number of measurements made,49362,0.0304083446089576,0.026720291796422,-0.0219634273120295,0.0827801165299447,0.255123804417887
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3143.Ankle spacing width,42031,-0.00765559295137877,0.00740842170206645,-0.022176099487429,0.00686491358467148,0.301453264447267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42030,-0.00117295521111621,0.00577344610252431,-0.0124889095720639,0.0101429991498314,0.839010231628784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3146.Speed of sound through heel,42031,-0.00800692428675054,0.00552927259979695,-0.0188442985823526,0.00283045000885149,0.147614285186675
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42031,-0.00586864911919837,0.00559753694988842,-0.0168398215409797,0.00510252330258294,0.294458346506023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3148.Heel bone mineral density (BMD),42019,-0.00634697640497401,0.00560828887710385,-0.0173392226040976,0.00464526979414954,0.257776051200113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X3526.Mother's age at death,47978,-0.0136869578744205,0.004465387526931,-0.0224391174272053,-0.00493479832163576,0.00217889800031864
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X3581.Age at menopause (last menstrual period),38313,-0.00200634140318009,0.00614934646299557,-0.0140590604706514,0.0100463776642912,0.744228292115606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32726,0.00288409303878872,0.00948704469104675,-0.0157105145556629,0.0214787006332404,0.761143273134783
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4100.Ankle spacing width (left),36628,0.0119633573014402,0.00981346024072727,-0.00727102477038527,0.0311977393732656,0.222853894905986
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36625,0.00379465161668087,0.0076218984239467,-0.0111442692942547,0.0187335725276164,0.618596227889301
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4103.Speed of sound through heel (left),36628,-0.00333135821093269,0.00727733041779598,-0.0175949258298128,0.0109322094079474,0.647129622013153
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36628,-0.00113513583741256,0.00737399564358106,-0.0155881672988314,0.0133178956240063,0.87766304638555
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4105.Heel bone mineral density (BMD) (left),36623,-0.00206385467715633,0.00737760308203518,-0.0165239567179453,0.0123962473636326,0.779680200535111
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36628,-0.00113179731749227,0.00737398614315058,-0.0155848101580674,0.0133212155230829,0.878019871616449
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4119.Ankle spacing width (right),36629,0.00961907847332577,0.00969442471447515,-0.00938199396704553,0.0286201509136971,0.321118665450413
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36628,-0.00140362385669725,0.00760980738239785,-0.016318846326197,0.0135115986128025,0.853666006735106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4122.Speed of sound through heel (right),36629,-0.00692830262615653,0.00727158255769525,-0.0211806044392392,0.00732399918692616,0.340726655315641
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36629,-0.00469704195862778,0.00736799265859115,-0.0191383075694664,0.00974422365221086,0.523823556051723
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4124.Heel bone mineral density (BMD) (right),36624,-0.00367226232471991,0.00736339642134981,-0.0181045193105655,0.0107599946611257,0.617992444111447
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36629,-0.0046927863511761,0.00736797735376843,-0.0191340219645622,0.00974844926221001,0.524198843644504
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4194.Pulse rate,36969,0.0215119639238972,0.00698046533369624,0.00783025186985255,0.0351936759779418,0.00206515788092412
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4195.Pulse wave reflection index,36969,-0.00539181164417659,0.00755049434741949,-0.0201907805651188,0.0094071572767656,0.475186485243134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4196.Pulse wave peak to peak time,36963,-0.0187550497710657,0.00688395047363545,-0.0322475926993912,-0.0052625068427402,0.00645507691313799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4198.Position of the pulse wave peak,36969,0.0186946262455349,0.00734929743080787,0.00429000328115145,0.0330992492099183,0.0109867821679339
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4199.Position of pulse wave notch,36969,0.0126149785069434,0.00705677698925932,-0.00121630439200481,0.0264462614058917,0.0738730035855271
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4200.Position of the shoulder on the pulse waveform,36969,0.0261560367766572,0.00723800461005336,0.0119695477409526,0.0403425258123618,0.000303755418574651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4269.Number of triplets attempted (left),36788,0.0592801727703318,0.105625937398682,-0.147746664531086,0.266307010071749,0.574659100494693
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4270.Volume level set by participant (left),36697,0.0312850912938944,0.0338751958824434,-0.0351102926356947,0.0976804752234835,0.355755684922814
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4276.Number of triplets attempted (right),36781,-0.033260214175649,0.102587449289119,-0.234331614782322,0.167811186431024,0.745785515905742
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4277.Volume level set by participant (right),36686,0.050373377216773,0.0341953132706706,-0.0166494367937413,0.117396191227287,0.140764040424262
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X4288.Time to answer,36976,0.0144987207490578,0.0082132935579241,-0.00159933462447344,0.0305967761225891,0.077556792883323
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X4290.Duration screen displayed,36976,0.0232686185976605,0.00775234425861358,0.00807402385077792,0.0384632133445431,0.00269510231801633
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X46.Hand grip strength (left),51778,-0.0472700376295102,0.0060798587068075,-0.0591865606948529,-0.0353535145641675,7.87487169991887e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X47.Hand grip strength (right),51803,-0.0444565179952329,0.00602769030445729,-0.0562707909919692,-0.0326422449984966,1.69518117430227e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X48.Waist circumference,51871,0.105130679088901,0.00920451839028417,0.0870898230439441,0.123171535133858,3.94155169661588e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X4803.Tinnitus,36875,0.0327102823956262,0.0381757327490862,-0.0421141537925828,0.107534718583835,0.391563133456974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X4825.Noisy workplace,36953,0.100311670010236,0.0438012218859484,0.0144612751137772,0.186162064906695,0.0220389384050262
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X4836.Loud music exposure frequency,36911,0.093302960988087,0.0719713480490204,-0.047760881187993,0.234366803164167,0.194879811036152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X49.Hip circumference,51865,-0.0339040412948146,0.00751436810863093,-0.0486322027877313,-0.019175879801898,6.45735179741676e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X50.Standing height,51843,-0.00885425232481477,0.00597080950660898,-0.0205570389577684,0.00284853430813883,0.138108713463043
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X5057.Number of older siblings,35762,0.0282742046028196,0.0373965226856885,-0.0450229798611299,0.101571389066769,0.449637301823487
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X51.Seated height,51757,0.00148869387890944,0.00555048956543143,-0.00939026566933617,0.012367653427155,0.788540535877646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5181.Ever had eye surgery,34418,0.0187001678066864,0.0750191994568203,-0.128337463128681,0.165737798742054,0.803160378778593
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5186.Duration visual-acuity screen displayed (right),34405,-0.00429276530607115,0.00853174341996658,-0.0210149824092057,0.0124294517970634,0.614878548000136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5188.Duration visual-acuity screen displayed (left),34404,0.000911011888833878,0.0087771220148002,-0.0162921472601745,0.0181141710378423,0.917336887589115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5190.Duration at which refractometer first shown (right),34333,-0.00132559599369456,0.00903347119676122,-0.0190311995393465,0.0163800075519574,0.883340866232935
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5193.Duration at which refractometer first shown (left),34331,-0.000545881507608359,0.00912487626332321,-0.0184306389837219,0.0173388759685051,0.95229858189532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5199.logMAR, initial (right)",34389,0.031118998533572,0.0437234608854753,-0.0545789848019596,0.116816981869104,0.476668204316491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5200.Final number of letters displayed (right),34389,-0.221954871482796,0.228433485830583,-0.66968450371074,0.225774760745148,0.331275453917727
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5201.logMAR, final (right)",34332,-0.00140767484600933,0.00944023598298412,-0.0199105373726582,0.0170951876806395,0.881469238817374
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5202.Number of rounds to result (right),34389,0.060325612957308,0.0402417048290578,-0.0185481285076453,0.139199354422261,0.133913267435195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5206.logMAR, initial (left)",34385,-0.015930754376192,0.0431988717714995,-0.100600543048331,0.068739034295947,0.712308922015749
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5207.Final number of letters displayed (left),34385,-0.0340868240407959,0.231052786557347,-0.486950285693195,0.418776637611604,0.882720778303984
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5208.logMAR, final (left)",34325,0.000377934585141289,0.00942260828199828,-0.0180903776475753,0.0188462468178579,0.968007517239973
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5209.Number of rounds to result (left),34383,-0.0275105596291347,0.0403701363522376,-0.10663602687952,0.051614907621251,0.495612096125841
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",34136,-0.0103659549965674,0.00886769453981646,-0.0277466362946077,0.00701472630147282,0.242477273685496
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",34136,-0.00708588906904135,0.00896163475696722,-0.0246506931926971,0.0104789150546144,0.429161936988749
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5256.Corneal hysteresis (right),34136,0.00684045225901445,0.00895985984650298,-0.0107208730401314,0.0244017775581603,0.44522836945829
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5257.Corneal resistance factor (right),34136,-3.36524831338275e-05,0.00903866334865023,-0.0177494326464883,0.0176821276802206,0.997029497019169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",34130,0.00191076710149544,0.00879944606455539,-0.0153361471850331,0.019157681388024,0.828103311869706
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",34130,-0.000667511682756863,0.00891458091052466,-0.0181400902673852,0.0168050669018715,0.940314307046769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5264.Corneal hysteresis (left),34130,0.00224265415643638,0.00903070407915853,-0.0154575258387143,0.0199428341515871,0.803884330092543
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5265.Corneal resistance factor (left),34130,0.000535092655935945,0.00908521322185874,-0.0172719252589072,0.0183421105707791,0.953036456969451
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34525,0.136260794061036,0.225697713946003,-0.30610672527313,0.578628313395201,0.54604793493025
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51811,0.0148202354026542,0.0224067585086444,-0.0290970112742889,0.0587374820795972,0.508350966105751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51811,-0.0401662552571231,0.0238161167134942,-0.0868458440155718,0.00651333350132554,0.0917103012572041
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51811,-0.0871414230541184,0.063169074673711,-0.210952809414592,0.0366699633063551,0.167755823687947
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51811,-0.0247722586863243,0.0096502647744565,-0.043686777644259,-0.00585773972838954,0.0102645438842897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51811,0.0193534749550187,0.00908662953936982,0.00154368105785387,0.0371632688521835,0.0331918819934851
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38133,-0.00857374291220415,0.013172038497992,-0.0343909383682685,0.0172434525438602,0.515124681746914
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38133,-0.0300131508295083,0.0281858453686658,-0.0852574077520932,0.0252311060930766,0.28698135335311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38133,0.014796161321666,0.0346192536591128,-0.0530575758501951,0.0826498984935271,0.669100567464641
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38133,0.029515188013092,0.0187241146962335,-0.00718407679152561,0.0662144528177096,0.114987565538084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51878,-0.0143380085306134,0.0189607489070784,-0.051501076388487,0.0228250593272602,0.449540616835866
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51878,-0.0143380085306134,0.0189607489070784,-0.051501076388487,0.0228250593272602,0.449540616835866
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51878,-0.0168611898753999,0.0151892498620267,-0.0466321196049723,0.0129097398541725,0.266978948973218
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51878,-0.0566580995085888,0.0263402115389716,-0.108284914124973,-0.00503128489220451,0.031485816051984
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51878,-0.0129840041926633,0.062626772773723,-0.13573247882916,0.109764470443834,0.835759052735463
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51878,-0.0180855596410603,0.0429910376645106,-0.102347993463501,0.0661768741813805,0.673991225153765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51878,0.0962617003954035,0.0705054262398005,-0.0419289350346055,0.234452335825412,0.172169457670729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51811,0.00139829249069594,0.0139769270678114,-0.0259964845622145,0.0287930695436064,0.920311143829817
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51811,0.0603312899802059,0.0235787477042305,0.0141169444799141,0.106545635480498,0.0105124412689434
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51811,0.0234804685509059,0.0139710065856824,-0.0039027043570316,0.0508636414588434,0.0928433864687533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51811,0.056757880908018,0.0197466168480327,0.0180545118858738,0.0954612499301622,0.00405289817189613
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51811,0.0222116345149696,0.0238948083747507,-0.0246221898995418,0.069045458929481,0.352609377513507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51811,0.063246231700811,0.0093349158451425,0.0449497966443317,0.0815426667572903,1.27256428039117e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,38717,0.0694744013288008,0.0212019611409283,0.0279185574925814,0.11103024516502,0.00105369789565518
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,38717,0.0542415108342903,0.0180338648588603,0.018895135710924,0.0895878859576566,0.00263869588377585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,38717,0.0515528869215119,0.0258859338951653,0.000816456486987846,0.102289317356036,0.0464500081419344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,38717,-0.0392245040124012,0.0203369101370694,-0.0790848478810573,0.000635839856254948,0.0537934932523564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51799,-0.00970130887709147,0.0322248128245598,-0.0728619420132287,0.0534593242590458,0.763378450744328
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51799,0.0177567097934283,0.0491745799989654,-0.0786254670045439,0.114138886591401,0.718031579958704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51799,0.0535587620045858,0.0770261897948724,-0.0974125699933642,0.204530094002536,0.486854514672466
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51799,-0.0332831801620363,0.0807843172161427,-0.191620441905676,0.125054081581603,0.680342953607071
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51799,-0.045216445429842,0.0264557997899197,-0.0970698130180846,0.00663692215840064,0.0874402873751951
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51799,-0.00881812048790803,0.0369191720301172,-0.0811796976669378,0.0635434566911217,0.811224561768336
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51799,-0.0344309803548091,0.0193904326667875,-0.0724362283817126,0.00357426767209444,0.0758010237984679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35896,0.0990998024045129,0.0258327738453649,0.0484675656675977,0.149732039141428,0.000126097650345892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35896,0.0643651567070273,0.0271945823245486,0.011063775350912,0.117666538063143,0.0179690699945952
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35896,0.0999327350543972,0.0378402346495975,0.0257658751411861,0.174099594967608,0.00828749677274302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35896,-0.00455538619817202,0.0159443054438343,-0.0358062248680873,0.0266954524717433,0.775112019886942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",40344,0.0281428645054735,0.0122798614048813,0.00407433615190603,0.0522113928590409,0.0219363099533143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",40344,-0.0239302014104829,0.0144593221508275,-0.0522704728261047,0.00441007000513898,0.0979523157671091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",40344,0.0285604793112347,0.0120242577487228,0.004992934123738,0.0521280244987314,0.0175544268851634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",40344,0.00694674208406524,0.0275776898581175,-0.047105530037845,0.0609990142059755,0.801125188198946
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",40344,0.015746719109741,0.0154485897695004,-0.0145325168384798,0.0460259550579619,0.308083553347522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",40344,0.0158455999723352,0.0222193588343978,-0.0277043433430844,0.0593955432877548,0.475771648088156
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51811,-0.00828492027939837,0.0259766801938794,-0.059199213459402,0.0426293729006052,0.749777353452994
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51811,-7.51595688197854e-06,0.0196992450840357,-0.038618036321592,0.038603004407828,0.999695582267344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51811,0.111877591785667,0.0497886713758331,0.0142917958890337,0.209463387682299,0.0246464878969657
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51811,-0.0327914230551017,0.0184060513561993,-0.0688672837132524,0.00328443760304888,0.0748349748821843
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51811,-0.00566012906710476,0.0216412917277624,-0.0480770608535191,0.0367568027193096,0.793676150389212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51811,0.0232835997898355,0.0259058335395099,-0.0274918339476039,0.0740590335272749,0.368780354511884
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51811,-0.0117000801004878,0.00873215300225925,-0.028815099984916,0.00541493978394031,0.180296223926939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34806,0.0241037625713622,0.0226982940130954,-0.0203848936943048,0.0685924188370291,0.288317887653499
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34806,0.0524880413621875,0.0279438468002184,-0.00228189836624051,0.107257981090616,0.0603864792175065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34806,-0.0527222029627906,0.0194916680608437,-0.0909258723620441,-0.014518533563537,0.00685397293396942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34806,0.0476172106549781,0.0182778056930092,0.01179271149668,0.0834417098132761,0.00920648309270056
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51903,0.028602650113223,0.0117175670634087,0.00563621866894198,0.051569081557504,0.0146540008644158
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51903,0.0108630739222273,0.0325580411590677,-0.0529506867495454,0.0746768345939999,0.738644828979967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51903,0.0272492673861629,0.00974282997914711,0.0081533206270346,0.0463452141452913,0.00516463305473974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51903,0.0148588901030572,0.00936885486992417,-0.00350406544199418,0.0332218456481086,0.112755986476704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51903,0.0372089912688115,0.0159860866437738,0.00587626144701484,0.0685417210906081,0.0199428392919772
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51903,0.0198890592549189,0.0119756627859882,-0.00358323980561795,0.0433613583154557,0.0967694645263241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51903,0.00320502996180227,0.00980979251446486,-0.0160221633665489,0.0224322232901534,0.743884645242184
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51903,0.1654906755955,0.0301910454447915,0.106316226523708,0.224665124667291,4.26344249919999e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45343,-0.046566084408442,0.010279772818579,-0.0667144391328568,-0.0264177296840272,5.9441339888394e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45343,-0.0164232605134997,0.0106763652458496,-0.037348936395365,0.00450241536836552,0.123999270345824
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45343,0.015805996244645,0.0112925394451403,-0.00632738106782986,0.03793937355712,0.161626925027093
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45343,-0.0062528954169792,0.0155017616792709,-0.0366363483083502,0.0241305574743918,0.68668377482784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45343,0.0197404488768381,0.0103021244245259,-0.000451714995232711,0.039932612748909,0.0553632301214545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51677,0.0223291149599976,0.0102334031246537,0.00227164483567632,0.0423865850843188,0.0291210804332065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51677,-0.0100695268379995,0.00831604519261651,-0.0263689754155278,0.00622992173952891,0.225963620486681
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51677,0.014283182662474,0.00860893004333385,-0.00259032022246031,0.0311566855474084,0.0971070910980983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51677,-0.0753048730936335,0.0186699717246643,-0.111898017673976,-0.0387117285132914,5.51393574330318e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51696,-0.0408631422711642,0.00925081691306418,-0.05899474342077,-0.0227315411215584,1.00432245207938e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51696,-0.0864641097899388,0.0183409071223334,-0.122412287749712,-0.0505159318301655,2.44023272871468e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51811,-0.00379775291575545,0.00843505601919473,-0.0203304627133771,0.0127349568818662,0.652545704581275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51811,-0.0180353639186273,0.00967699030471399,-0.0370022649158667,0.000931537078612116,0.0623716091422686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51811,-0.0308221113183025,0.0146928205482434,-0.0596200395928596,-0.00202418304374541,0.0359368178071873
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51811,0.0027506721660124,0.0200814818043516,-0.0366090321705166,0.0421103765025415,0.891051334483435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51811,0.0321801063433231,0.0254158644819961,-0.0176349880413891,0.0819952007280354,0.205475107852028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51811,-0.00804445610666431,0.0241884179491023,-0.0554537552869048,0.0393648430735761,0.739458417764643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42031,-0.00586566211701604,0.0055975109551646,-0.0168367835891387,0.00510545935510658,0.294701909945296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X864.Number of days or week walked 10+ minutes,51325,-0.0752654643399181,0.0201498763328089,-0.114759221952224,-0.0357717067276127,0.00018797581113357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X874.Duration of walks,48293,-0.00464897485393285,0.00459335775312102,-0.0136519560500501,0.00435400634218436,0.311499163831505
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50398,-0.0722000766123412,0.0196087044519292,-0.110633137338122,-0.03376701588656,0.000231947455740592
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X894.Duration of moderate activity,45629,-0.0628138995578512,0.0242870573304177,-0.11041653192547,-0.0152112671902325,0.00970943367092076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X90087.No-wear time bias adjusted average acceleration,33389,-0.0268016232307185,0.0109432659386239,-0.0482504244704213,-0.00535282199101558,0.0143602897643039
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50312,-0.096172413132342,0.0203139889159294,-0.135987831407564,-0.0563569948571203,2.21244035185495e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X914.Duration of vigorous activity,40218,-0.00356246803308852,0.00563626211416835,-0.0146095417768585,0.00748460571068143,0.527359364425097
